Research Authority - Technion
R&D Foundation
Active Funding Resources in Medicine and Life
Sciences
[All funds | Life | Exact and Materials | Social &
Humanities]
For
assistance call Robi – 2152 robertg@technion.ac.il,
Iris – 1272 irisbr@trdf.technion.ac.il, Luba – 1477 lubak@technion.ac.il
The list is arranged by deadlines
chronological order (dd.mm), first Israeli divided by RFPs and Workshops, then
Foreign
Deadlines are highlighted in Green
Please note:
1) No
overhead implies that overhead costs to the academic institute
are not covered by the grant.
2) Overhead XX% implies that overhead
costs to the academic institute are covered partially.
Please contact Research
Authority if planning to submit.
16.4 | Era-Net (MOH): THCS- Transforming
Health and Care Systems – Healthcare of the Future
(Obligatory
"Intent to apply” deadline)
Submission
deadline for proposals: 14 May 2024
Webinar
on March 12th from 16.00 – 17.30 CET. click here to register.
Consortia of minimum 3 partners from
3 eligible countries
aiming to encourage the optimization of
patient care pathways and contribute to the transition towards more
sustainable, efficient, resilient, ethical, high-quality, and accessible
person-centered healthcare systems.
Funding for the Israeli partner:
€140K over 3 years (€180K for coordination).
* A short abstract and
budget should be sent to the ministry of Health (MOH) prior to
pre
proposal
submission. Call us for clarifications and MOH abstract
forms (tel. 2152, 1272,1477).
https://www.thcspartnership.eu/funding/pre-announcement-of-the-second-joint-transnational-call.kl
1.5 | Bar-Ilan
University Press: President's Prize
äĺöŕú äńôřéí ůě ŕĺđéářńéčú ář-ŕéěď: ôřń đůéŕ ŕĺđéářńéčú ářÎŕéěď ěńôř äîç÷ř äčĺá áéĺúř ěůđú úůô"ă éĺňđ÷ ěçéáĺř
î÷ĺřé ůě ńôř îç÷ř ĺňéĺď ůđëúá áňářéú ĺéĺâů ěäĺöŕú äńôřéí ůě ŕĺđéářńéčú ář-ŕéěď.
îčřú äôřń äéŕ ěäĺ÷éř ĺěňĺăă ëúéáä îç÷řéú îňĺěä äôĺđä âí ěöéáĺř äîůëéě äřçá.
ńëĺí äôřń: 30,000 ¤ ěî÷ĺí äřŕůĺď ĺ- 10,000 ¤ ěî÷ĺí äůđé.
1.5 | US-Israel Binational Agricultural
Research and Development Fund (BARD)/ NIFA-BARD-MOST:
Nutritional Security (Pre-application)
The
nutritional Security program is a new funding track that enhances U.S.-Israel
collaboration on joint scientific innovation to address the multifaceted
challenges of nutritional security. The program focuses on solutions to promote
health, reduce hunger and address diet-related health issues while enhancing
sustainability. Beyond food quality, the program places specific emphasis on
the affordability, accessibility, and overall availability of nutritionally
balanced diets that are crucial for human well-being.
Priority areas:
*Impact of
nutrition and diet on health and well-being
*Food Science,
processing and safety
*Sustainable
solutions for nutritional security
Funding:
Up to 480,000 NIS for 3 years.
Collaboration is limited to
American research scientists who have been funded by NIFA (the list
of projects).
https://www.bard-isus.com/fundingTypes/Details/24
10.5 | American Cancer Society: Yosemite Award - AI and/or immuno-oncology
Supports innovative research to develop
methodologies, establish feasibility, or pilot high risk/high reward projects
to advance the prevention, diagnosis, or treatment of cancer.
Funding: up to $300K for 1 or 2 years
https://www.ra.trdf.co.il/files/ACS Yosemite Grant Program.pdf
15.5 | Ministry of Health and Naomi
Foundation: Kadar-Sheba Prize for
Excellence in Research
Inspired to
promote and accelerate excellence in biomedical research, the Naomi Foundation
has decided to celebrate the scientific achievements of a leading
physician-scientist within all Israeli medical centers. Award of $100,000 to
a single recipient, with $75,000 dedicated to supporting research and
$25,000 as a personal award to the recipient.
https://www.ra.trdf.co.il/files/Kadar_Sheba_2024.pdf
15.5 | VATAT – MOST ‘Proof
of Concept’ Research Projects
ĺú"ú-îůřă äîăň: úëđéú ěîéîĺď
îç÷řé äĺëçú äéúëđĺú
äĺĺňăä ěúëđĺď
ĺú÷öĺá (ĺú"ú) ĺîůřă îůřă äîăň îňĺđééđéí ěúîĺę áîůĺúó ááéöĺň äĺëçú äéúëđĺú
ěîç÷ř îăňé ĺŕ÷ăîé áňě ôĺčđöéŕě ěééůĺí îńçřé.
÷ĺě ÷ĺřŕ ćä áŕ ěúîĺę áîç÷ř áůěá äĺëçú
äéúëđĺú áěáă (POC:
Proof of Concept)
ëěĺîř, îç÷ř áĺ ŕéď âĺó îńçřé äîňĺđééď ěäů÷éň (îôŕú řîú äáůěĺú äčëđĺěĺâéú).
éĺăâů ëé ä÷ĺě
ä÷ĺřŕ ôúĺç ěëě úçĺîé äăňú äŕ÷ăîééí, ŕę äöňú äîç÷ř đăřůú ěäéĺú áňěú ôĺčđöéŕě
ééůĺîé ářĺř (úňůééúé, öéáĺřé ŕĺ çářúé).
âĺáä ĺîůę äîňđ÷ - ňă 350,000 ¤ ěú÷ĺôä
ůě 18-24 çĺăůéí.
äöňĺú äîç÷ř éëĺěĺú ěëěĺě ůĺúôéí
îäčëđéĺď ŕĺ îîĺńăĺú ŕ÷ăîééí ŕçřéí.
äčëđéĺď řůŕé ěäâéů 10 äöňĺú îčňîĺ, ňě ëď éňřę úäěéę áçéřä ôđéîé ůéđĺäě áěůëú äîđě"î.
çĺ÷řéí äîňĺđééđéí ěäâéů äöňä,
îúá÷ůéí ěůěĺç äöňä îěŕä, áŕđâěéú, ňă 15.5 ěëúĺáú: ra-tec@technion.ac.il
îáđä ääöňä:
^ ääöňä úĺâů áŕđâěéú ňě âáé äčôńéí ůá÷éůĺř ěîčä
* ňîĺă ůňř: ëĺúřú, ůîĺú äçĺ÷řéí îâéůé ääöňä, îçě÷ä ĺôřčé
÷ůř (ŕéď čĺôń îéĺçă).
* úëđéú äîç÷ř: (ňă 5
ňîĺăéí, ěŕ ëĺěě î÷ĺřĺú)
* ú÷öéá (ňă ňîĺă ŕçă)
* đńôç éůéîĺú (ňă 2 ňîĺăéí(
* ÷ĺřĺú çééí, ëĺěě řůéîú
ôřńĺîéí řěĺĺđčééí (ňă 2 ňîĺăéí ěëě çĺ÷ř)
çĺ÷řéí ůäöňúí
úŕĺůř áúäěéę äáçéřä äîĺńăéú, éĺëěĺ ěňřĺę ĺěňăëď ŕú äöňúí ňă ěîĺňă ääâůä ěîîîď – 18.6.24.
á÷éůĺř äáŕ îĺôéň
đĺńç ňăëđé ůě ä÷ĺě ä÷ĺřŕ, čĺôńé äâůä (éůîůĺ âí ěäâůä äôđéîéú áčëđéĺď) ĺëď ńéëĺí
ůě îôâů îúňđééđéí ůđňřę ěŕçřĺđä:
www.gov.il/he/departments/publications/Call_for_bids/rfp02042024
19.5/30.8 | Tokushima University
– Technion Collaboration (3rd round) - any scientific topic of mutual interest
Following
a Memorandum of Understanding between the Nichia Corporation, Tokushima University
and the Technion, Nichia Corporation intends to fund up
to 5 joint
research projects of researchers from TU and the Technion.
Research domains: any scientific topic of mutual interest.
Funding: Projects are planned for two years with a total funding of $100K/year/project ($50K/year/PI).
Application procedure:
Stage 1 - An optional initial one-page pre-proposal + one-page CV will be submitted by email to TISI Office - tisi_office@tokushima-u.ac.jp or to Technion Research Authority - ra-tec@trdf.technion.ac.il by May 31.
This stage is optional and meant to help Technion PIs in finding a suitable partner at Tokushima University and vice-versa, therefore, there is no requirement for a partner from the other institution. The pre-proposals will serve only to identify possible TU/Technion collaborators (but not for any kind of pre-selection).
The pre-proposals submitted at each university will be disclosed to the researchers from the other university to allow a matching process.
Both universities' PIs will actively contact each other based on their Keywords, Research Fields, and Topics to form international research groups.
Stage 2 - Successfully matched PIs jointly prepare a collaborative research proposal and submit it from Tokushima University's PI to TISI office - tisi_office@tokushima-u.ac.jp. by August 30.
One PI can apply with two collaborative proposals.
The Project Guidance Team will notify the results in November 2024.
Call for Proposals, forms and Application Guidelines: www.acot.tokushima-u.ac.jp/Information/call-for-tisi-collaborative-research-project-phase-3/
Tokushima Researcher’s information:
* Educators and Researcher’s Directory: http://pub2.db.tokushima-u.ac.jp/ERD/organization/10992/index-en.html
* Names and Research Fields: www.isc.tokushima-u.ac.jp/english/app/wp-content/uploads/2024/02/faculty-research-interests.pdf
*
Video Messages: www.acot.tokushima-u.ac.jp/ourcontents/audio-visual
1.6 | Israel Institute for Advanced Studies (IIAS): Michael Bruno Award for
Israeli Scholars in STEM Fields
The Michael Bruno
Memorial Award is granted annually to three outstanding mid-career Israeli
scholars who have demonstrated an exceptional originality of mind, dedication and ground-breaking impact in their research, and
who have succeeded in influencing and re-shaping their field of expertise. This
award, a personal prize in the amount of 200,000 NIS, is both the highest
recognition of past accomplishments and a vote of confidence in the laureates’
future achievements and contributions to research and Israeli academia.
Eligible candidates
must be faculty members of STEM fields in Israeli research institutions who are
under 50 years of age as of February 15, 2024 or up to
15 years after first University appointment.
https://www.ra.trdf.co.il/files/BrunoOpenCall.pdf
17.6 | Israel
National Institute for Health Policy and Health Services Research (NIHP):
pre-proposals
äîëĺď
äěŕĺîé ěç÷ř ůřĺúé äářéŕĺú ĺîăéđéĺú äářéŕĺú: äöňĺú î÷ăîéĺú
úçĺîéí:
îăéđéĺú ářéŕĺú, ŕřâĺď ůřĺúé äářéŕĺú, ëěëěú ářéŕĺú, ŕéëĺú ůřĺúé äářéŕĺú
äůđä
úéđúď ňăéôĺú ěđĺůŕéí:
1. îňřę äůé÷ĺí äôéćé
áéůřŕě
2. ňéöĺá ĺôéúĺç úçĺí
ářéŕĺú äđôů
3. öîöĺí ôňřé ářéŕĺú
áéď îřëć ěôřéôřéä
áđĺůŕéí
ŕěä úéđúď ňăéôĺú ěîç÷řéí áňěé ôĺčđöéŕě ěîăéđéĺú áú ééůĺí ĺěúĺëđéĺú îňůéĺú ůđéúď
ěŕîöď.
îéîĺď:
îç÷ř řâéě: ňă 150,000 ¤ ěůđä ĺçöé.
îç÷ř
î÷éó ňă 300,000 ¤ ěůđúééí ňă ůěĺů ůđéí.
https://www.israelhpr.org.il/research-grants/
1.12 | Israel Institute for Advanced Studies (IIAS): 2026-2027
Individual Fellowships and Research Groups (all disciplines)
Individual Fellowships: scholars from Israel and abroad are
invited to submit proposals for residencies (5 or 10 months) at the IIAS.
Proposals must seek to be innovative, with the potential to impact research in
the field. Two or three scholars who collaborate on the same project should
apply individually and state clearly that they wish to work together.
https://iias.huji.ac.il/Individual_researchers
https://www.ra.trdf.co.il/files/IF.pdf
Research Groups: scholars from Israel and abroad (5-8 core fellows) invited to submit proposals (which must seek to be innovative with potential impact on their research field) to spend residency (3, 5, 10 months) at IIAS.
https://iias.huji.ac.il/RG_Application
https://www.ra.trdf.co.il/files/RG.pdf
https://iias.huji.ac.il/open-calls
NSF-BSF
programs:
Israeli researchers can join research proposals submitted by US PI(s) to
the NSF, in the programs listed below. Two applications per calendar
year (Oct 1 – Sept 30) are permitted
The Israeli budget is funded by the BSF as follows: up to
$80K/yr for experimental studies and $55K/yr for theoretical and computer-based studies.
Pay attention to the application deadlines. While many programs
are open all year long, some still have specific time limits.
Details
on all NSF-BSF programs: www.bsf.org.il/funding-opportunities/nsf-bsf-joint-research-grants/the-programs/
·
Biocomputing through
EnGINeering Organoid Intelligence (BEGIN OI): Jan. 17
·
Economics and Decision Sciences: Jan. 24
·
Computing and Communication Foundations
(CCF): Open All Year
·
Computer Networks and Systems
(CNS): Open All Year
·
Information and Intelligence Systems
(IIS): Open All Year
·
Cyber Security and
Privacy (SaTC): Open All Year - In any case,
Israeli PIs will consult with Ms. Yael Dressler in the BSF office (yael@bsf.org.il) regarding their project description and
budget request before advancing the preparation and submission of their
proposal.
·
Foundational Research in
Robotics: Open All Year
·
Physics: Various Deadlines
·
Materials (DMR): Open All Year
·
Astronomy and Astrophysics: Nov. 15
·
Mathematics: Various Deadlines
·
Mathematical and Scientific Foundations of
Deep Learning: Various Deadlines
·
Electrical, Communications and Cyber
Systems (ECCS): Open All Year
·
Chemical, Bioengineering, Environmental
and Transport Systems (CBET): Open All Year
·
Civil, Mechanical and Manufacturing
Innovation (CMMI): Open All Year
·
Earth Sciences (GEO): Open All Year
·
Atmospheric and Geospace Sci.: Open
All Year
·
Marine Oceanography: Various Deadlines
·
EAGER (Early-Concept applications in all
the active NSF-BSF programs): Open All Year
·
Chemistry: Various Deadlines
DFG
– German Science Foundation: Research Grant for Middle East Collaboration
Researchers
working in Germany who meet the DFG’s eligibility requirements can submit a
joint proposal to fund domestic (German) and international project costs with
colleagues from:
· Israel
(bilateral projects) or
· Israel and
Palestine or the following countries that neighbour
Israel: Egypt, Jordan, Lebanon and Syria (trilateral
or multilateral projects).
· Funding
levels are typically ~ €300K over 3 years for all partners.
www.dfg.de/en/research_funding/programmes/international_cooperation/middle_east_collaboration
www.dfg.de/formulare/54_016/index.jsp
ICL (Israeli Chemicals Ltd): ICL Open Innovation
(Crop Nutrition and Applied Agronomy)
ICL is looking to fund
research projects in the following domains:
Crop Nutrition:
·
Enhanced Efficiency Fertilizers
·
Biostimulants
·
Biodegradable CRF Coating
·
Nitrogen Fixation
·
Organic Fertilizers
·
Secondary nutrients
·
Delivery Platform
·
Ammonia synthesis
·
Increased P-availability
Applied Agronomy
·
Efficient
fertilizers application
·
Regenerative
Agriculture practical methods
·
Water use
efficiency practical methods
·
Nutrient
balance (plant, soil, water, atmosphere) sensing/analysis
·
GHG
emissions sensing/analysis
·
Soil
microbiome sensing/analysis
·
Soil/groundwater
contamination sensing/analysis
·
Yield
estimation by remote sensing
·
Plant
nutrition’s DSS
Funding: The budget for the
selected proposals will be negotiated with ICL
For further details, please
contact Adi Perelman Adi.Perelman@icl-group.com
https://www.ra.trdf.co.il/files/ICL
Open Innovation .pdf
Israel
Insurance Association Research Fund: Research Grants on Natural Hazards
The
Fund welcomes applications for financial support for the purpose of conducting
research on insurance matters, especially on the subject of
motor bodily injury insurance, and other insurance branches of
importance to the public interest (i.e Earthquake and
other Natural hazards risks and insurance). Funding: ask the Research Authority
- 2152
Eng: www.igudbit.org.il/eng/Index.asp?CategoryID=451
Heb: www.igudbit.org.il/Index.asp?CategoryID=420
Guidelines
and form: www.igudbit.org.il/_Uploads/1616keren(1).doc
The
Israel Securities Authority (ISA) (HA'RASHUT LE'NIAROT ERECH): Research Grants
Research
grants in amount of 5,000-40,000 NIS in subjects
relevant to ISA activity.
http://www.isa.gov.il/GeneralResearch/179/Pages/default.aspx
Shaare Zedek Medical Center: Corona samples
äîřëć äřôĺŕé ůňřé öă÷: ÷ĺě ÷ĺřŕ ěůéîĺů
áăâéîĺú ÷ĺřĺđä
ăâéîĺú áéĺěĺâéú îçĺěé SARS-CoV-2 ĺî÷áĺöú
áé÷ĺřú, ěřáĺú ńřĺí, ôěćîä, ăí îěŕ, ĺîčĺůéí, ëĺěě ëě äîéăň ä÷ěéđé ä÷ůĺř ěăâéîĺú
ŕěĺ. ňě äîç÷řéí ěńééň á÷éăĺí äéăň áúçĺí ćä, ĺěňĺăă ÷éăĺí ůéúĺôé äôňĺěä ňí äîřëć
äřôĺŕé.
řůŕéí ěäâéů çĺ÷řéí ŕĺ çářĺú áŕřő
ĺáçĺ"ě, ĺáěáă ůéäéä ůĺúó îůňřé öă÷. áîéăä ĺŕéď ůĺúó, đéúď ěá÷ů çéáĺř ůĺúó
îúŕéí.
- äăĺâîŕĺú, äěéĺĺé
ä÷ěéđé, ĺ÷áěú ŕéůĺřéí řâĺěčĺřééí ěîç÷ř đéúđĺú ěěŕ ňěĺú ĺîîĺîđĺú ňě éăé ňě éăé
äřůĺú ěîç÷ř ĺôéúĺç ň"ů ŕéćđářâ áîřëć äřôĺŕé ůňřé öă÷.
ŕđŕ öřĺ ňéîđĺ ÷ůř
áîéăä ĺáëĺĺđúëí ěäâéů äöňä. äöňĺú îç÷ř éů ěůěĺç ě:
research@szmc.org.il ňě âáé äčĺôń á÷éůĺř. úůĺáä
řŕůĺđéú úéđúď áúĺę 14 éĺí. ěîéăň đĺńó, đéúď ěôđĺú ěîéëě âřůĺđé, řëćú îňđ÷é îç÷ř:
michalge@szmc.org.il
https://www.ra.trdf.co.il/files/Corona
samples call.jpg
Foreign:
14.4 | Pfizer: Independent Research
Grants
Investigator-Sponsored
Research (ISR): An ISR is a type of grant that supports an independent research study
where the investigator or organization is the sponsor of the study and where
Pfizer provides financial and/or nonfinancial support for the development or
refinement of specific and defined medical knowledge relating to a Pfizer
asset.
General
Research: general research projects focused on the development or refinement
of specific and defined medical knowledge unrelated to a Pfizer asset.
Funding:
not specified.
https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research
14.4 | Josef Steiner Cancer Research Foundation Award 2025
Supports
early career investigator (typically 40 years or less (Involved in projects in
basic and/or clinical cancer research (specifically, the translation of new
basic/theoretical insights into clinical applications) and Able to provide the
infrastructure needed to carry out the proposed project.
Funding:
up to CHF 1M over 4 years and a personal prize of CHF 50'000.
https://www.steinerstiftung.unibe.ch/guidelines.aspx
15.4 | Angelman Syndrome Foundation
Priority will be given to the following
topics:
- Projects studying or correcting the
heterozygous effect of non-UBE3A genes in deletion.
- Projects studying the potential results of
increasing UBE3A after therapies or for some subtypes of AS.
- Projects studying delivery of therapies and
potential for improvement.
- Symptomatic therapies that impact the daily
life of people with Angelman syndrome and their families.
Proposals that do not address these topics
are still welcome and will be given full consideration.
Funding: $100K per year for 1 or two years
https://www.angelman.org/as-research/call-for-proposals
15.4 | The Prostate Cancer Foundation (PCF): Young Investigator
Awards
Encourage young investigators working on
prostate cancer health disparities
Funding: $75K per year for 3 years (no overhead)
https://www.pcf.org/science-impact/for-researchers/open-rfas/
https://www.ra.trdf.co.il/files/RFA_2024-Young-Investigator-Award_1.23.24.pdf
16.4 | American Association for Cancer
Research (AACR): Cancer Disparities Research Fellowship
Encourage
and support postdoctoral or clinical research fellows to conduct cancer
disparities research and to establish a successful career path in this field.
The proposed research may be in basic, translational, clinical, or population
sciences research and must have direct applicability and relevance to cancer
disparities. Work under the auspices of a mentor.
Funding:
$130K for 2 years (no overhead)
https://www.aacr.org/grants/aacr-cancer-disparities-research-fellowship/
16.4 | Wellcome Trust:
Discovery Awards
provides
funding for established researchers and teams from any discipline who want to
pursue bold and creative research ideas to deliver significant shifts in
understanding that could improve human life, health, and wellbeing.
Funding:
the average
size of a Discovery Award is Ł3.5 million, although the trust have supported awards from Ł700,000 to Ł8 million.
Please note: the
host organisation of the lead applicant needs to be based in UK, Republic
of Ireland, Low- or middle-income countries
https://wellcome.org/grant-funding/schemes/discovery-awards
17.4 |
Preeclampsia Foundation: Vision Grant 2024
Initial funding for young investigators (within 10 years from PhD) to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome;
Funding: up to $20K. The Foundation’s affiliate, Preeclampsia Foundation Canada, will award one Vision Grant up to $25K CAD to study HELLP Syndrome.
www.preeclampsia.org/research-funding
18.4 | The Peanut Institute: Peanut Nutrition Grants
General Research
Grant
Enhance our
understanding of how consuming peanuts, peanut butter, and peanut products
affects health in various populations.
Funding: $25K-$250K for
1 year
https://www.ra.trdf.co.il/files/General
grant.pdf
Public Health
Research Grant
Effect of consumption
of peanuts/peanut products in the diet on human health, and for reducing the
public health burden of chronic diseases. Specifically, robust designs,
including large scale and/or long-term human studies. The main PI should be
based in the US.
Funding: $350K - $650K
for multi-year projects
https://www.ra.trdf.co.il/files/Public
Health Call.pdf
https://peanut-institute.com/research-resources/peanut-nutrition-grant/
18.4 | Pfizer: Diagnosis and Diagnostic Tests for
Metallo-β-Lactamase (MBL)
Producing Bacterial Infections
Foster healthcare professional education to
support them in making evidence-informed decisions in
the diagnosis and management of patients with
Metallo-β-Lactamase(MBL) producing bacterial infections.
Funding: up to $100K
https://www.ra.trdf.co.il/files/Producing
Bacterial Infections IME.pdf
18.4 | The Gateway for Cancer Research
Seek to bring urgency to the process of
cancer research for patients who are looking for treatments today and are faced
with difficult decisions without innovative, life-saving options. Gateway will place increasing emphasis on
funding patient-centered and novel research.
Gateway Traditional Grant Program
Core grants funding early phase clinical
trials for cancers of all types
Funding: from $200K to $1.5M for 2-5 years
Integrative Research
Funding integrative oncology research that
pairs conventional therapies with evidence-based, complementary therapies to
manage symptoms and side effects from treatment. This also aims to increase
quality of life during treatment.
Society for Integrative Oncology (SIO)
Support integrative clinical trials
conducted by principal investigators and institutions among its membership.
SIO’s mission is to advance evidence-based, comprehensive, integrative
healthcare to improve the lives of people affected by cancer.
Decentralized Clinical Trial Initiative
(DCTI)
Fund research leveraging site-less,
technology-informed trials, with the objective of bringing clinical trials
directly to patients’ doorsteps.
https://gatewaycr.smapply.org/prog/gfcr_all_grant_programs_-_v122023/
19.4 | Alternatives Research & Development Foundation
(ARDF): Annual open grant program
Promote the development, validation, and
adoption of non-animal methods in biomedical research, product testing, and
education.
Proposal evaluation is based on scientific
merit, feasibility, and the potential to reduce or replace the use of animals
in the near future.
Funding: max $40K
https://www.ardf-online.org/ardf-grants.html
22.4 | Defeat Duchenne Canada: Research
Grants - competitive LOI
Focused on treating
and improving the lives of individuals living with Duchenne muscular dystrophy.
Successful proposals are expected to be of high scientific merit, demonstrate a
clear, probable, and timely path toward clinical implementation. Priority -
most significant impact on boys and young men living with Duchenne.
Funding: no
maximal limit for 1-3 years
https://www.ra.trdf.co.il/files/Criteria-FINAL.pdf
https://defeatduchenne.ca/granting-process/
23.4 | Cystic Fibrosis Foundation: Health Equity Team
Science Award - LOI
Research projects should have the potential to improve
our understanding of or have a positive impact on identified barriers to
optimal health outcomes for all people with CF related to race and ethnicity,
sexual orientation or gender, or socioeconomic status.
At least two but no more than four investigators may
be included on a given project. Co-investigators may be at the same or
different institutions.
Applicants must speak with program staff prior to
submission to ensure the project design is in line with the goals of this
request for application.
Funding: up to $200K per year for up to 4 years
https://www.cff.org/researchers/health-equity-team-science-award
https://www.ra.trdf.co.il/files/Health
Equity Team Science Award.pdf
23.4 | VELUX STIFTUNG
Daylight
Research
Highly
interdisciplinary, on the effects and utilization of daylight in three fields:
- Daylight
and humans
- Daylight and nature
- Daylight
technology
Healthy
Aging
Bio-psycho-social
approach and support research that aims to sustain or increase the functional
ability and intrinsic capacity of older people.
Funding:
CHF 50-70K ($57-114K) per year for 1-4 years (possible to exceed with
pre-approval)
https://veluxstiftung.ch/funding-areas/daylight-research/
https://veluxstiftung.ch/funding-areas/healthy-ageing/
29.4 | LUPUS Research Alliance: Translational Bridge Award - competitive
LO'Is
Milestone-driven
projects with strong, relatively near-term commercialization potential or with
an immediate opportunity for clinical evaluation. All projects should advance
the discovery of potential commercial entities or clinical products with a
clear and direct relevance to people with lupus and offer the potential to
improve diagnosis or standard of care for the disease or usher in a cure.
Funding: up to $450K
over 2 years
https://www.ra.trdf.co.il/files/2024-TBA-RFA.pdf
https://www.lupusresearch.org/for-researchers/funding-opportunities/
30.4 | The Louis Bachelier Network: ReFinE Call for Projects
To promote and enrich scientific research
on the links between real estate and finance, considering the physical nature
of assets.
physical nature of assets (location and
geographical diversification, fixed costs, irreversibility). Open to all
academic disciplines.
Priority themes:
- Climate and real estate issues
- The liquidity of open-ended real estate
funds
- Land development and value enhancement
- Differentiated effects of land
artificialization depending on the type of construction
- City centers, suburbs, and commercial
real estate
- Evaluating macroprudential policies in
residential real estate
- Public policy, incentives, and energy
transition
- Design of property and real estate
taxation (local tax competition) and national taxation (IFI and ISF)
Funding: up to 4,000 EUR, seminars and
conferences organized by the Institute as part of the network.
https://www.institutlouisbachelier.org/en/calls/current-calls/
https://docs.google.com/forms/d/e/1FAIpQLSfcugYeZVHNsgDD4jWmLp8SoDXwssfZftViB_KpQhxqIIfUdw/viewform
30.4 | The Morton Cure Paralysis Fund (MCPF): Research Grants
(another deadline on
Oct. 31)
Funds activities that
hold promise of identifying therapies (cures) for paralysis in humans. Has
particular focus of placing projects in the research pipeline, that is,
enabling scientists to develop the proof concept data necessary to apply for
larger NIH grants. The development of effective therapies for chronic injury is
a high priority for the organization.
Basic research will be supported if it has clear potential to accelerate
progress at the applied end of the continuum and/or if it reflects innovative
research or a ‘change of direction’.
Funding: $5K to $75K
for 1 year (second year considered, no overhead)
https://www.ra.trdf.co.il/files/MCPF-Research-Guidelines-2023.doc
https://mcpf.org/new-investigator-grant-application/
30.4 | Thermo Fisher Scientific: Oncomine Clinical
Research Grant - Molecular Profiling in Oncology
Investigator-initiated
studies and education projects, on molecular profiling in oncology, with the
goal to increase high quality molecular profiling and to help democratize the
future of precision medicine.
Proposals addressing
unmet diagnostic needs using next-generation sequencing for both solid and
hematological cancers.
Funding: up to $200K
30.4 | Grifols - LOIs
Albus Award
Focused on innovative ideas related to
albumin and its role as a therapeutic product.
https://www.albus-awards.com/en/home
GATRA award
Foster a scientific network and the
knowledge in the use of Antithrombin as a therapeutic product
Funding: €50,000 per 1 year
Proposals may include, but are not limited
to: efficacy, mechanism of action, safety and tolerability,
quality of life and pharmacoeconomics.
https://www.gatra-awards.com/en/home
30.4 | The UK Defense
and Security Accelerator (DASA): Sample Preservation, Analysis, And Attribution (SPAA)
This
competition seeks proposals for innovations that could help the successful
identification of chemical and biological (ChemBio) materials and/or bring
perpetrators to justice.
The challenges outlined in this competition are
diverse in nature, therefore it is anticipated that proposals will address a
certain area rather than covering multiple requirements.
There are three main challenge areas where innovative solutions
and approaches are being sought:
·
Challenge 1: New screening technologies for
rapidly detecting or identifying the presence or class of hazardous ChemBio
materials in a sample
·
Challenge 2: New sample
collection/preservation systems that better maintain the integrity and
viability of hazardous samples
·
Challenge 3: New analytical approaches to
improve the forensic exploitation and the attribution of ChemBio materials
and/or recovered chemical/biological weapons material (RC/BWM)
Up to Ł1 million is available to fund multiple innovations at
Technology Readiness level (TRL) 2-4 to deliver fieldable prototypes/software
(TRL6+) to support investigations into ChemBio incidents.
https://www.gov.uk/government/news/sample-preservation-analysis-and-attribution-spaa
30.4 | Wellcome Trust: Bioimaging Technology
Development Awards
This
award will fund teams of technology developers and users to create novel
bioimaging tools at the cell-tissue scale. Successful teams will develop
technologies that answer ambitious research questions or that overcome barriers
to bioimaging work in low-resource settings. Awarded teams
will develop tools and technologies to overcome barriers to progress in
bioimaging. Specifically, they will advance technologies to investigate
biological phenomena at the cell-tissue scale.
Funding:
Foundation phase: up to Ł500k; Scale-up phase: you
should ask for the resources you need for your program.
Duration
of funding: Up to 8 years, spanning two phases: a foundation
phase for the first 18 months, followed by a scale-up phase up to a maximum of
6.5 additional
years.
Requires UK
PI
https://wellcome.org/grant-funding/schemes/bioimaging-technology-development-awards
1.5 | Environmental Research & Education
Foundation - Pre-proposals
Topic
areas:
Waste
minimization, Recycling, Waste conversion to energy, biofuels, chemicals, or
other useful products. This includes,
but is not limited to, the following technologies:
Waste-to-energy,
Anaerobic digestion, Composting. Other thermal or biological conversion
technologies, Strategies to promote diversion to higher and better uses (e.g.
organics diversion, market analysis, optimized material management, logistics,
etc.), Landfilling.
Funding:
average of $160K for about 2 years
https://erefdn.org/research-grants-projects/how-to-apply-for-grant/
1.5 | National Center
for Responsible Gaming (NCRG): Seed Grant (LOI)
Seed Grants
can be used to explore the etiology, prevention and treatment of gambling
disorders, and the development and evaluation of responsible gambling
strategies.
Funding: up
to $40,000
per year per year in direct costs and up to 15% indirect
costs for 1
year .
https://www.icrg.org/information/apply-for-icrg-funding
2.5 | Cystic Fibrosis
Foundation
Pilot
and Feasibility Awards
Intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.
Funding:
$50K per year for up to 2 years
https://www.ra.trdf.co.il/files/Pilot-and-Feasibility-Awards.pdf
https://www.cff.org/researchers/pilot-and-feasibility-awards
Path
to a Cure Pilot and Feasibility Awards
Supports research that will accelerate the discovery and development of therapies to restore cystic fibrosis transmembrane conductance regulator (CFTR) function in all patients with cystic fibrosis.
Funding:
$50,000 per year for up to 2 years
https://www.ra.trdf.co.il/files/PTAC-Pilot-and-Feasibility-Award.pdf
https://www.cff.org/researchers/path-cure-academic-programs
Research
Grants
To support (non-Path to a Cure related) basic science research that will provide new insights that contribute to the understanding of the basic etiology and pathogenesis of cystic fibrosis.
Funding:
$150K per year for up to 3 years
https://www.ra.trdf.co.il/files/Research-Grants.pdf
https://www.cff.org/researchers/research-grants
Path
to a Cure Research Grants
To support basic science research that may enable the development of new therapies that directly impact CFTR function.
Funding:
$150K per year for up to 3 years
https://www.ra.trdf.co.il/files/PTAC-Research-Grants.pdf
https://www.cff.org/researchers/research-grants
2.5 | The European Foundation for
the Study of Diabetes (EFSD) and Sanofi: European Diabetes Research Programme
on Autoimmunity in Type 1 Diabetes
To stimulate and accelerate European research aimed at
improving understanding of any aspect of autoimmunity in type 1 diabetes, its
pathogenesis, screening and monitoring, its clinical course, and its
interventions. Grants are offered for basic and clinical studies.
Funding: up to 100K EUR for 1 year or longer (Non-profit)
2.5 | European
Crohn’s and Colitis Organization (ECCO) - LOIs
Pioneer Award
Encourage and support innovative basic and/or
clinical scientific research in the area of
Inflammatory Bowel Diseases (IBD) across Europe.
Funding: 300K EUR for 2 years
Global Grant
Extend the outreach and global perspective of IBD
research and may focus on aspects of IBD pathogenesis (e.g. environmental
impact, genetics), epidemiology and/or clinical care, among others.
Applications must be multicenter and address knowledge gaps and/or unmet needs
relevant to low and lower-middle income countries and feature strong
contributions from these countries. At least one Principal Investigator who is
from a low- or lower-middle income country.
Funding: 300K EUR for 2 years
European
Crohn´s and Colitis Organisation - ECCO - Fellowships and Grants (ecco-ibd.eu)
2.5 | Juvenile Diabetes Research Foundation (JDRF): Project Concepts (LOI)
Aim: funding for single or multiple
investigators to address critical gaps and challenges and potential
breakthroughs in Type 1 diabetes research. Funding: The budget and duration
of funding are variable and continued funding is based on satisfactory effort
and quarterly progress on milestones.
https://grantcenter.jdrf.org/rfa/project-concepts-strategic-research-agreement/
6.5 | Crohn's & Colitis Foundation of America – LOIs
Senior Research Awards
To provide established researchers with funds to generate sufficient
preliminary data to become competitive for funds from other sources such as the
National Institutes of Health (NIH).
Funding: $130K per year for 1-3 years (10% indirect costs)
https://www.crohnscolitisfoundation.org/research/grants-fellowships/senior-research-awards
Litwin
Inflammatory Bowel Disease (IBD) Pioneers
Supports
innovative clinical and translational research projects with the potential to
impact the treatment of IBD patients in the near future.
Funding:
$130K (clinical trials), $110K (lab-studies) per year for 1-2 years (10%
indirect costs)
https://www.crohnscolitisfoundation.org/research/grants-fellowships/litwin-ibd-pioneers
Summer 2024 | Inflammatory Bowel Disease (IBD)
Ventures
Discovery
or development of a novel product with the potential to help patients.
Funding:
up to $500K per year. Funded programs will be offered accelerator resources and
advising.
6.5 | DOD/CDMRP: Peer Reviewed Medical
Research Program (PRMRP)– Pre-Proposals/LOI
Autoimmune Disorders and Immunology: Celiac Disease | Computational Biology for Precision Health| Food Allergies | Guillain-Barré Syndrome| Inflammatory Bowel Disease| Proteomics| Scleroderma
Cardiovascular
Health: Cardiomyopathy: Computational
Biology for Precision Health |
Congenital
Heart Disease | Proteomics | Vascular Malformations
Hemorrhage Control and Blood Products: Hemorrhage Control | Proteomics | Trauma
Infectious Diseases: Computational Biology for Precision Health | Congenital Cytomegalovirus | Far-UVC Germicidal Light | Hepatitis B | Malaria | Proteomics
Internal Medicine: Accelerated Aging Processes Associated with Military Service | Computational Biology for Precision Health | Focal Segmental Glomerulosclerosis | Interstitial Cystitis | Lymphedema | Nephrotic Syndrome | Pancreatitis | Polycystic Kidney
Neuroscience: Computational Biology for Precision Health | Eating Disorders | Maternal Mental Health | Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome | Neuroactive Steroids | Peripheral Neuropathy | Proteomics | Suicide Prevention
Respiratory Health: Computational Biology for Precision Health | Proteomics | Pulmonary Fibrosis | Respiratory Health
Orthopaedic Medicine: Accelerated Aging Processes Associated with Military Service | Computational Biology for Precision Health | Musculoskeletal Disorders Related to Acute and Chronic Bone Conditions and Injuries | Proteomics
Rare Diseases and Conditions: Computational Biology for Precision Health | Dystonia | Ehlers-Danlos Syndrome | Epidermolysis Bullosa | Fibrous Dysplasia/McCune-Albright Syndrome | Fragile X | Frontotemporal Degeneration | Hereditary Ataxia | Hydrocephalus | Mitochondrial Disease | Myotonic Dystrophy | Proteomics | Rett Syndrome | Sickle-Cell Disease | Von Hippel-Lindau Syndrome
Award Mechanism:
Discovery Award: up to $275K for 2 years
Investigator-Initiated Research Award: Up to $1M over 4 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583103
6.5 | Pfizer and Bristol-Myers Squibb (BMS): Grant program
To enhance understanding of the oral anticoagulant treatment of
patients with atrial fibrillation and/or venous thromboembolism. Grant
proposals should leverage
innovative data and content delivery mechanisms including an
omnichannel approach.
Requests for regional/multi-country educational proposals are
within scope, however, single-country programs will not be considered.
Funding: Up to $300K
https://www.ra.trdf.co.il/files/GMG_2024_IM_PfizerBMSCVIME.pdf
10.5 | LifeArc: Motor Neuron
Disease Translational Challenge - expression of interest (EOI)
Fund high quality innovative proposals that set out a rigorous
evidence-based approach to the preclinical translation of repurposed drug
candidates and drug candidate combinations, uniquely including funding for
independent replication of project results through LifeArc.
Funding: up to 750K EUR
13.5 | Male Contraceptive Initiative: Research
Projects - competitive LOI's
Support research projects with application in the development of
reversible non-hormonal contraceptives delivered to men.
The David Sokal Innovation Awards
Projects in discovery or exploratory phases of contraceptive
development, including hit-to-lead optimization.
Funding: up to $200K for 2 years
Development Awards
Projects in early-to-late stages of contraceptive development, including
preclinical studies and beyond.
Funding: up to $400K for 2 years
https://www.ra.trdf.co.il/files/mci_2024-100_300_rfa_announcement.pdf
www.malecontraceptive.org/funding.html
13.5 | Alzheimer’s Drug Discovery Foundation
(ADDF) – LOIs
*
Drug Development: up to
$5M.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/drug-development-rfp
*
Neuroimaging and CSF Biomarker: $600K for 1 year
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers
*
Prevention: up to
$5M for
clinical trials based on stage and scope of research.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/prevention-pipeline
Please
note overhead is not covered.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities
13.5 | DOD/CDMRP: Peer Reviewed
Medical Research Program (PRMRP)– Pre-Proposals/LOI
Autoimmune Disorders and Immunology: Celiac Disease | Computational Biology for Precision Health| Food Allergies | Guillain-Barré Syndrome| Inflammatory Bowel Disease| Proteomics| Scleroderma
Cardiovascular
Health: Cardiomyopathy: Computational
Biology for Precision Health |
Congenital
Heart Disease | Proteomics | Vascular Malformations
Hemorrhage Control and Blood Products: Hemorrhage Control | Proteomics | Trauma
Infectious Diseases: Computational Biology for Precision Health | Congenital Cytomegalovirus | Far-UVC Germicidal Light | Hepatitis B | Malaria | Proteomics
Internal Medicine: Accelerated Aging Processes Associated with Military Service | Computational Biology for Precision Health | Focal Segmental Glomerulosclerosis | Interstitial Cystitis | Lymphedema | Nephrotic Syndrome | Pancreatitis | Polycystic Kidney
Neuroscience: Computational Biology for Precision Health | Eating Disorders | Maternal Mental Health | Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome | Neuroactive Steroids | Peripheral Neuropathy | Proteomics | Suicide Prevention
Respiratory Health: Computational Biology for Precision Health | Proteomics | Pulmonary Fibrosis | Respiratory Health
Orthopaedic Medicine: Accelerated Aging Processes Associated with Military Service | Computational Biology for Precision Health | Musculoskeletal Disorders Related to Acute and Chronic Bone Conditions and Injuries | Proteomics
Rare Diseases and Conditions: Computational Biology for Precision Health | Dystonia | Ehlers-Danlos Syndrome | Epidermolysis Bullosa | Fibrous Dysplasia/McCune-Albright Syndrome | Fragile X | Frontotemporal Degeneration | Hereditary Ataxia | Hydrocephalus | Mitochondrial Disease | Myotonic Dystrophy | Proteomics | Rett Syndrome | Sickle-Cell Disease | Von Hippel-Lindau Syndrome
Award Mechanism:
Impact Award: Up to $2.6M over 4 years.
Clinical Trial Award: Funding limit not defined. Duration 4 years.
Lifestyle and Behavioral Health Interventions Research Award: Up to $3M over 4 years
Technology/Therapeutic Development Award: Up to $4M over 4 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583103
14.5 | U.S. DOD/CDMRP:
Ovarian Cancer Research Program (OCRP)– Pre-proposals
Investigator-Initiated
Research Award:
up to $1.2M for 4 years
Ovarian
Cancer Academy - Early-Career Investigator Award: up to $725K for 4years
Pilot
Award:
up to $300K for 2 year
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581101
14.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- Pre-proposals
Breakthrough
Award Level 3: up to $5M for 4 years
Breakthrough
Award Level 4: up to $15M for 4 years.
Transformative
Breast Cancer Consortium Award: up to $25M for 4 years.
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101
15.5 | The Children’s Heart Foundation:
Independent Research Awards - Competitive LIO's
Fund research that directly impacts patients living with congenital heart disease, over the course of their lifetime, through advancing the diagnosis, treatment, and prevention of congenital heart defects.
Funding: up to $150K per year for 2 years.
https://www.childrensheartfoundation.org/for-researchers/
15.5 | Osteology Foundation: Applied Research Grant in oral tissue
regeneration
A new flagship programme to
actively promote translational and clinical research.
Funding: 200K Swiss francs (~$227K)
https://osteology.org/funding-opportunities/applied-research-grants/
https://www.ra.trdf.co.il/files/granting-guidelinesapprg_v1.pdf
15.5 | American Association for Cancer Research
(AACR) & Victoria’s Secret Global Fund: Women’s Cancers Career
Development Award
Aims to foster innovation
in the understanding, prevention, interception, early detection, diagnosis, and
treatment of breast and gynecologic cancers to eliminate cancer health
disparities and improve patient outcome
Funding: $$206K for 2 years.
15.5 | International Rett Syndrome Foundation:
Innovation Awards - competitive LOI's
Advance research aimed at investigating the underlying pathology of the
disorder and identifying novel therapeutic approaches to treat and cure Rett
syndrome.
Funding: Up to $300K for 2 years
https://www.ra.trdf.co.il/files/2024-Innovation-Awards-RFP-LOI.pdf
https://www.rettsyndrome.org/research/for-researchers/research-grants/
16.5 | Parkinson's UK: Non-drug approaches -
preproposals
Fund creative, innovative research into non-drug approaches that will
play a vital part in helping people living with Parkinson’s manage their daily
challenges and take control of life with Parkinson’s. Co-applicants and
collaborators may be based at institutions outside the UK or biotech companies.
Funding: up to 200K EUR for up to 24 months
https://www.parkinsons.org.uk/research/grants-non-drug-approaches
16.5 | Michael J. Fox Parkinson Foundation: Parkinson's
Disease Therapeutics Pipeline Program (Full proposal)
Applicants may submit a pre-proposal application at any time. Pre-proposals
will be reviewed by MJFF within three weeks of submission. Applicants whose
pre-proposal is selected for further consideration will be invited to
submit a full proposal through one of the four review cycles.
This program seeks to advance therapeutic development through
pre-clinical and/or clinical testing of approaches addressing unmet needs of
people with Parkinson’s disease (PD). The program is set up to benefit
therapeutics with clear potential to prevent, stop, or delay disease
progression or to reduce the burden of daily symptoms.
The Therapeutics Pipeline Program is only open to industry and industry-academia
collaborations.
Funding: Award amounts for this program may range from $250,000 for
smaller, targeted programs to upwards of $2M for larger, multi-stage
preclinical and/or clinical programs
Duration: 1-2 years for pre-clinical programs, 2-3 years for
clinical programs
16.5 |
American Association for Cancer Research (AACR): Breast Cancer Research
Foundation-AACR NextGen Grant for Transformative Cancer Research (LOI)
Aim:
support creative, paradigm-shifting cancer research that may not be funded
through conventional channels. It is expected that these grants will catalyze
significant scientific discoveries and help talented young investigators gain
scientific Independence.
Applicants
must belong to racial or ethnic group(s) that has been shown to be
traditionally excluded in the cancer-related sciences workforce.
Funding:
$450,000 for 3 years.
16.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- (LOI)
Breakthrough
Award Levels 1 and 2: up to $2M for up to 4 years
Transformative
Breast Cancer Consortium Development Award: up to $100K for 1 year.
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101
16.5 |
U.S. DOD/CDMRP: Autism Research Program
(ARP) – Pre-proposals
Career Development Award: up to
$550K for 3 years
Clinical Trial Award: up to
$2.2M for 4 years
Idea Development Award: up to
$550K for 3 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=577102
20.5 | DOD/CDMRP: Spinal
Cord Injury Research Program (SCIRP)– Pre-application
Clinical Translation
Research Award: up to $1.35M for 3
years
Clinical Trial Award: up to $3.1M for 4 years
Investigator-Initiated
Research Award: up to $600K for 3
years
Translational Research Award: up to $1.35M for 3 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583101
22.5 | DOD/CDMRP: Peer
Reviewed Alzheimer's Research Program (PRARP)– LOI
Transforming Care Award: up to $1.6M for 4 years
Transforming Diagnosis
Award: up to $2 M for 4 years
Transforming Research
Award: up to $1M for 3 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583104
23.5 | DOD/CDMRP: Breast Cancer Research Program (BCRP)- (LOI)
Era
of Hope Scholar Award: up to $3.5M for up to 4 years
Clinical
Research Extension Award: up to $6M for 4 years.
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=573101
24.5 | U.S. DOD/CDMRP:
Amyotrophic Lateral Sclerosis Research Program (ALSRP)– LOI
Clinical Outcomes and Biomarkers Award:
up to $750K for 3 years
Pilot Clinical Trial Award: up to $2M for 4 years
Therapeutic Development Award: up to $1.5M for 3 years
Therapeutic Idea Award: up to $600K for 2 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581102
27.5 | The European Foundation for the Study of Diabetes (EFSD)/Boehringer
Ingelheim European Research Programme on "Multi-System Challenges in
Diabetes"
"Multi-System Challenges of Diabetes,
Obesity and Cardiometabolic Disease” to encourage innovative basic and clinical
projects aimed at:
- Advancing current knowledge in the
inter-organ crosstalk and related pathophysiology in Diabetes, Obesity and
Cardiometabolic Disease
- Assessing the adaptation and impact of
guidelines directed medical care in management of diabetes, Obesity and
Cardiometabolic Disease
Funding: up to 100K EUR (up to 300K EUR in
exceptional cases) for 1 year or longer (Non-profit)
28.5 | DOD/CDMRP: Lung Cancer Research
Program (LCRP)
Career Development
Award: up to $375K for 3 years (LOI)
Concept Award: up to $120K for 1 year (LOI)
Idea Development
Award: up to $525K for 3 years (preproposal)
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583102
30.5 | Lundbeck Foundation: LF Ascending Investigators
To support talented and established scientists
to further develop their careers through support of research that may result in
a better fundamental understanding of the brain and/or improved prevention,
diagnosis and treatment of brain and nervous-system diseases.
Foreign-based researchers can be co-applicant
and/or collaborators in the proposed project.
Funding: up to DKK 5M ($730K) over 4 years
https://lundbeckfonden.com/uddelinger-priser/ansoegere/apply-grants/lf-ascending-investigators
https://www.ra.trdf.co.il/files/Ascending Investigators.pdf
31.5 | Fritz Thyssen Foundation: Conferences in Medicine and Natural
Sciences, Humanities and Social Sciences
(more deadlines in: August 31,
November 30)
Clear connection to the German research system
(topic, scientist, institute). Interdisciplinary projects welcomed.
Areas of support:
- History, Language & Culture
- State, Economy and
Society
- Medicine and the Natural Sciences
15 to 20 speakers, not earlier than 6 months
after application submission, not for a staged conference.
https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/
1.6 | Boehringer Ingelheim
Foundation: Heinrich Wieland Prize
This 250,000
euros international prize honors outstanding research on biologically active
molecules and systems in the fields of chemistry, biochemistry, and physiology
as well as their clinical importance.
https://www.heinrich-wieland-prize.de/heinrich-wieland-prize.html
3.6 | U.S. DOD/CDMRP:
Ovarian Cancer Research Program (OCRP)– LOI
Clinical Trial Award: up to $2M for 4 years
Clinical
Trial Translational Endpoints Research Award: up to $1M for 3 years
Ovarian Cancer Academy – Leadership Award: up to $1.75M for 3 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581101
4.6 | Volkswagen Shiftung: Scoping workshops
Researchers at German universities and research
institutions, international co-applicants
For researchers who want to take a step beyond
their current activities and think about the future of their field of research.
Funded scoping workshops are held in Hannover
at the Xplanatorium Herrenhausen
Palace
conference center. Workshops are supported with
funds covering personnel as well as non-personnel or travel costs.
https://www.volkswagenstiftung.de/en/funding/funding-offer/scoping-workshops
https://www.ra.trdf.co.il/files/MB_394_e.pdf
5.6 |
DOD/CDMRP: Epilepsy Research Program (ERP)– LOI
Idea Development Award: up to $650K
for 3 years
Leveraging Research Award: up to $500K
for 3 years
Research Partnership Award: up to $1.2M
for 3 years
Virtual Post-Traumatic Epilepsy Research
Center - Faculty Award: up to $525K for 3 years
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=563101
11.6 | CURE Epilepsy: Catalyst Award - LOIs
Supports nimble development of data
necessary to advance ideas toward larger commercialization funding
opportunities.
Above the level of Assistant
Professor.
Funding: $250K for 2 years (no
overhead)
https://www.ra.trdf.co.il/files/2023-CURE-Epilepsy-Catalyst-Award-Guidelines_Final_52323.pdf
https://www.cureepilepsy.org/grants-program/
13.6 | Simons
Foundation (SFARI): Pilot Award in ASD (autism spectrum disorder)
Intended to provide early support for exploratory ideas, particularly
those with novel hypotheses. Appropriate projects for this mechanism include those
considered higher risk but with the potential for transformative results.
Investigators new to the field of autism are encouraged to apply for these
awards.
Funding: up to $300K
for 2 years.
www.sfari.org/grant/pilot-awards-request-for-applications/
15.6 | The LAM Foundation: In-cycle Grant Opportunities -
Competitive LOIs
Pilot and Feasibility Grant
To encourage the development and testing
of new hypotheses and/or new methods in research areas relevant to LAM (Lymphangioleiomyomatosis).
Funding: up to $50K for up to 1 year
Established Investigator Research Grant
Encourage the development of new
information that contributes to LAM Research Priorities. All proposals must be
hypothesis generating or hypothesis testing and provide sufficient preliminary
data to justify The LAM Foundation’s support.
Funding: up to $150K for up to 3 years
https://www.thelamfoundation.org/investigators/funding-opportunities/
15.6 | GenScript Life
Science: Research Grant Program
Supporting breakthroughs in life science research areas, including but
not limited to those indicated below. This program is designed to empower
researchers by providing grant funding earmarked explicitly for purchasing GenScript reagents and services.
Funding: $100K for up to 12 months
https://www.genscript.com/grantprogram.html
https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf
15.6 | Ulverscroft
Foundation: Grants for visually impaired people
Supports
projects which will have a positive effect on the quality of life of visually
impaired people (VI). Funding: not specified.
www.ulverscroft-foundation.org.uk/grants/
20.6 | DARPA: Biological Technologies Office
(BTO)– Biological Technologies- abstracts
Abstracts may be
submitted on a rolling
basis until deadline
Bio-complexity | Bio-Devices | Bio-systems | Disease | Health | Injury | Med-Devices | Neuroscience | Opportunities | Restoration | Sensors | Space | Syn-Bio |
BTO is
interested in submissions related to the following topic areas:
·
General
Topics (that fit BTO`s mission)
·
Human
Performance
·
Materials,
Sensors, Processing
·
Ecosystem
and Environmental
·
Biosecurity
and Biosafety
·
Biomedical
and Biodefense
Please see BAA for further
information.
https://sam.gov/opp/597bf60984314db1b3ecfce393677c75/view
24.6 | CURE Parkinson's: Quarterly Research Grant Funding Programme
(another deadline on 21.10)
Funds preclinical and clinical research focused
on slowing, stopping, or reversing Parkinson’s.
Funding: up to Ł250K (GBP) and prioritize
projects that are likely to lead to clinical trials in people with Parkinson’s
within 5 years.
https://cureparkinsons.org.uk/for-researchers/apply-for-funding/quarterly-research-grant-funding/
27.6 | LEO Foundation Award:
Region Asia-Pacific
Call opens on May. 16
Advancing the understanding and treatment of skin diseases and strengthening the pipeline of excellent dermatology researchers. It recognizes promising young talents and hopefully provides a boost to their future careers.Criterions: 30-40 years old, scientific merit (5 peer-reviewed publications), active scientist within skin-related research, become a ‘LEO Foundation Alumni’.
Funding: $100K
https://leo-foundation.org/en/grants-and-awards/research-grants / Call guidelines
28.6 | Grifols: GRAIT Awards - LOIs
Annual European and Middle East award to encourage clinicians and
researchers to increase insight into immune thrombocytopenia (ITP) or to
improve knowledge of the Spleen Tyrosine Kinase (SYK) inhibition as mechanism
of action.
Funding: €50,000 per 1.5 years
https://www.grait-awards.com/en/home
30.6 | The Matsumae International Foundation:
Research Fellowship
Support program for young researches who want
to conduct reseach in Japan
Fellowship period: six months between April 2025 to March 2026.
Fields of research such as natural science, engineering, and medicine
are given first priority.
Funding: arrival funding of 120K JPY ($790) and monthly allowence of 220K JPY ($1450)
https://www.ra.trdf.co.il/files/fellowship-announcement-2025_EN.pdf
https://www.mif-japan.org/en/fellowship/announcement/
30.6 | Radala
Foundation: Research Grants in ALS
Funds an established, leading PIs pursue a potentially ground-breaking,
high-risk project in basic research in ALS.
Funding: 200K CHF (~800,000 NIS) for
2 years (one or two grants will be
funded).
www.radala-foundation.com/index.html
1.7 | Ines Mandl Research Foundation
(IMRF): Connective Tissue Diseases
IMRF provides research funding in the fight against connective tissue diseases, including, but not limited to emphysema and genetic diseases, especially those related to elastin and elastase concentrating in the causes as opposed to the cure or treatment of the disease. Research may also include the fields of immunology and bio-chemistry.
Funding: Up to $100K over 1-3 years. No overhead.
1.7 | Manpei
Suzuki Diabetes Foundation: International Prize for Diabetes Research
For original and excellent achievements in diabetes
research that will contribute to the health and welfare of all people.
Funding: $200K and Japanese objet
d'art
https://manpeisuzukiprize.org/
16.7 | Thrasher Research Fund:
E.W. "Al" Thrasher Awards - Concept papers
Focus
on projects that are changing pediatric clinical care. Each award is a novel
approach to problems plaguing pediatrics.
Funding:
up to $550K for up to 3 years (7% overhead)
https://www.thrasherresearch.org/al-thrasher-award?lang=eng#downloads0
17.7 | DOD/CDMRP: Lung Cancer Research
Program (LCRP)- LOI
Patient-Centered
Outcomes and Survivorship Award: up to $650K for 3 years.
https://ebrap.org/eBRAP/public/Program.htm
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=583102
18.7 | Michael J. Fox Parkinson Foundation:
Parkinson's Disease Therapeutics Pipeline Program (Full proposal)
Applicants may submit a pre-proposal application at any time. Pre-proposals
will be reviewed by MJFF within three weeks of submission. Applicants whose
pre-proposal is selected for further consideration will be invited to
submit a full proposal through one of the four review cycles.
This program seeks to advance therapeutic development through
pre-clinical and/or clinical testing of approaches addressing unmet needs of
people with Parkinson’s disease (PD). The program is set up to benefit
therapeutics with clear potential to prevent, stop, or delay disease
progression or to reduce the burden of daily symptoms.
The Therapeutics Pipeline Program is only open to industry and industry-academia
collaborations.
Funding: Award amounts for this program may range from $250,000 for
smaller, targeted programs to upwards of $2M for larger, multi-stage
preclinical and/or clinical programs
Duration: 1-2 years for pre-clinical programs, 2-3 years for
clinical programs
29.7 | Cystic Fibrosis Foundation: Path to a
Cure, collaborative Research Grant
To facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches.
Funding: max of $1,000,000 per year for up to 3 years. The application must consist of at least two (2) projects, each led by an independent
investigator.
https://www.cff.org/researchers/path-cure-collaborative-research-grant
30.7 | Wellcome
Trust: Discovery Awards
provides funding for established researchers and
teams from any discipline who want to pursue bold and creative research ideas
to deliver significant shifts in understanding that could improve human life,
health, and wellbeing.
Funding: the average size of a
Discovery Award is Ł3.5 million, although the
trust have supported awards from Ł700,000 to Ł8 million.
Please note: the host organisation of the lead applicant
needs to be based in UK, Republic of Ireland, Low- or middle-income countries
https://wellcome.org/grant-funding/schemes/discovery-awards
31.7 | National Eczema Association
Engagement Research Grant – up to $5,000
Small research grants for emerging investigators intended to explore a new
research concept, pilot a new experiment or undertake a novel or secondary data
analysis.
Catalyst Research Grant – up to $50,000
Designed to support talented early-career scientists on the path toward
becoming the next generation of eczema thought leaders by supporting
hypothesis-driven research projects.
Childhood Eczema Challenge Grant – up to $50,000
This collaborative grant with the Pediatric Dermatology Research
Alliance (PeDRA) supports targeted clinical research investigations focused on
pediatric eczema. This award is intended to stimulate early and mid-career
scientists as they seek to build and sustain careers as research investigators
and future thought leaders within this critical field of study.
Spotlight Research Grant – up to $60,000
This award is intended to promote research in topic areas of special
interest that relate to NEA’s advancement of our overall research priorities
for eczema
Eczema Champion Research Grant – up to $100,000
Encourages proven researchers to continue research on emerging or ongoing
challenges in eczema or bring their expertise to the field of eczema.
https://nationaleczema.org/research/research-we-fund/for-researchers/
7.8 | Foundation for Food & Agriculture Research (FFAR): Harvest for Health
Breakthrough Crop Challenge (Part 2: Predictive Model Development and
Validation)
The purpose is to develop a predictive model to
determine a crop’s potential as a source of ingredients with the following
functional properties:
• Thickeners, emulsifiers, and stabilizers
• Bulking agents
• Taste and flavor enhancers
• High nutrient density (specific nutrients to be
proposed by applicants)
(Participating in the seed
funding part is not a requirement for applying to the predictive model
development and validation part).
Funding: $1.0 million (one award)
Informational webinar will be hold on October 3, at noon EDT, register to attend the
webinar (mandatory).
15.8 | Friedreich's
Ataxia Research Alliance (FARA) - LOIs
General Research Grant
Supports research across the
spectrum from basic research through drug development and clinical research
programs in Friedreich's Ataxia (FA).
Funding: $125K for 1-2
years
FARA is willing to consider
ad-hoc proposals of cycle that are high-value projects. For more information,
please contact FARA at grants@curefa.org
Postdoctoral Research Award
To expand and retain young
investigators in the FA biomedical research space. Eligible applicants are
postdoctoral trainees with fewer than 7 years working as a postdoctoral
trainee, accounting for career disruptions.
Funding: $100K for 1-2
years
https://www.curefa.org/grant/grant-apply
16.8 | John Templeton Foundation: Core Funding Areas - Online Funding
Inquiry Form
Invest in bold
ideas from contrarian thinkers — ideas that cross disciplinary boundaries and
challenge conventional assumptions. Welcomes grant
applications to support field-leading research and high-impact public
engagement programs in these areas.
·
Character Virtue Development
·
Individual Freedom & Free Markets
·
Mathematical & Physical Sciences
·
Religion, Science, and Society
Funding: Not specified. Duration:
up to 5 years.
www.templeton.org/what-we-fund/core-funding-areas
25.8 | Pfizer: Independent Research
Grants
Investigator-Sponsored
Research (ISR): An ISR is a type of grant that supports an independent research
study where the investigator or organization is the sponsor of the study and
where Pfizer provides financial and/or nonfinancial support for the development
or refinement of specific and defined medical knowledge relating to a Pfizer
asset.
General
Research: general research projects focused on the development or refinement
of specific and defined medical knowledge unrelated to a Pfizer asset.
Funding:
not specified.
https://www.pfizer.com/about/programs-policies/grants/investigator-sponsored-research
31.8 | AO Foundation: Biomedical Innovation Funding
Eligible projects must
focus on either:
Clinical tools and
technologies for any element of the entire patient journey in musculoskeletal
disorders, from diagnosis to post-operative care; or
Educational tools, platforms or channels for lifelong training of surgeons.
https://www.aofoundation.org/what-we-do/innovation-translation/innovation-funding
31.8 | Fritz Thyssen Foundation: Conferences in Medicine and Natural
Sciences, Humanities and Social Sciences
(another
deadline in: November 30)
Clear connection to the
German research system (topic, scientist, institute). Interdisciplinary
projects welcomed.
Areas of support:
- History, Language
& Culture
- State, Economy and Society
- Medicine and the
Natural Sciences
15 to 20 speakers, not
earlier than 6 months after application submission, not for a staged
conference.
https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/
31.8 | International Team for Implantology (ITI): Research Grant
Projects in the field
of implant dentistry and related areas.
Small Grant (SG)
For young researchers
who wish to expand their scope and level of responsibility or want to establish
a track record in implant dentistry.
Funding: $50K
Large Grant (LG)
This grant type will be
awarded to experienced researchers/research groups only.
Funding: $200K
https://www.iti.org/research/research-grants
1.9 | Fritz Thyssen Foundation: Medicine and Natural Sciences, Humanities
and Social Sciences
Projects with clear
connection to the German research system (topic, scientist, institute).
Interdisciplinary projects welcomed.
Areas of support:
- History, Language
& Culture
- State, Economy and Society
- Medicine and the
Natural Sciences
Funding: not specified.
Up to 3 years.
Travel
Subsidies applications related to a project can be submitted seperatly at any time.
Note: please
contact Research Authority if planning to submit - overhead not covered
https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/
1.9 | Mizutani Foundation for Glycoscience
Provides research grants to proposals for basic and
applied studies on glycoconjugate.
Funding: up to 7,000,000 yen (~$48K) for 1 year.
https://mizutanifdn.or.jp/grant/apply.html
2.9 | European Pain Federation EFIC: The EFIC-Grünenthal-Grant (E-G-G)
Clinical and human experimental pain research including innovative educational initiatives aimed at
improving diagnosis and treatment of pain. Research proposals on animals,
computer simulations, cell lines, etc. will not be considered. For early-career
scientists, holding a PhD degree (for a maximum of 7 years on 2 September
2024).
Funding: up to 50K EUR for 2 years
https://europeanpainfederation.eu/efic-grunenthal-grant/
https://www.grunenthal.com/en/world-free-of-pain/initiatives/e-g-g
3.9 | Parkinson's UK: Drug Accelerator Awards - preproposals
Projects that will have a clear focus on translational
drug development to make a difference to those affected by Parkinson’s.Co-applicants
and collaborators may be based at institutions outside the UK or biotech
companies.
Funding: up to 100K EUR for up to 12 months. For
projects involving in vivo work, a duration of 12 to 18 months and an award
amount of up to Ł150K will be considered.
https://www.parkinsons.org.uk/research/drug-accelerator-awards
https://www.ra.trdf.co.il/files/Drug
accelerator award.pdf
A virtual workshop will be held on July 12, for
registration: https://parkinsons-org-uk.zoom.us/meeting/register/tZErceGoqTksH9FX37TTu4mZp91ax5UZ2tbk#/registration
3.9 | Volkswagen Shiftung:
Pioneering Research – Exploring the Unknown Unknown
For visionary projects from the field of basic
research. Addresses outstanding researchers from all disciplines and is open to
various funding formats.
Funding: up to 500K EUR for up to 3 years
6.9 | March of Dimes: Discovery Grants
Researchers seeking to make consequential
translational discoveries that will drastically alter clinical care for
pregnant women and babies, whether through evidence-based prevention,
diagnosis, or intervention.
Funding: $200K for 2 years
https://www.marchofdimes.org/our-work/research/grants-awards/discovery-research-grants
12.9 | LEO Foundation: Dermatology research
projects
Call
opens on Aug. 1
- Improve the understanding of skin biology as well as the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.
- Address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.
Funding: DKK 2-4 million ($300-600K), %5 Overhead is covered
https://leo-foundation.org/en/grants-and-awards/research-grants/
\ Call Guidelines
13.9 | ChadTough Defeat DIPG Foundation:
Fellowship Grant
Intended to incentivize
novel approaches and spark innovation to find a cure for the deadliest
pediatric brain cancer, DIPG.
Post-doctoral fellows
under the guidance of a mentor to help develop the next generation of leaders
in DIPG research.
Funding: up to
$135K/year for 3 years, No overhead
https://www.chadtough.org/research/grant-application/
15.9 | GenScript Life Science: Research Grant
Program
Supporting breakthroughs in life science research
areas, including but not limited to those indicated below. This program is
designed to empower researchers by providing grant funding earmarked explicitly
for purchasing GenScript reagents and services.
Funding: $100K for up to 12 months
https://www.genscript.com/grantprogram.html
https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf
15.9 |
Ulverscroft Foundation: Grants for visually
impaired people
Supports projects which will have a positive effect on the quality of
life of visually impaired people (VI). Funding: not specified.
www.ulverscroft-foundation.org.uk/grants/
16.9 |
National Scleroderma Foundation: Established Investigator Grant
To propose pilot studies to obtain preliminary data dealing with a
highly innovative and/or highly relevant theme related to the disease,
that is likely to lead to more substantial unlimited research project
grants from federal or non-federal sources.
Funding: up to $200K for up to 2 years (Non-profit)
https://scleroderma.org/grant-opportunities/
23.9 | VELUX STIFTUNG - Forestry
- Innovative,
sustainable and integrative forest management to develop and provide solutions
for adapting to or mitigating climate change, promoting biodiversity, providing
resilient ecosystem services while supplying sustainable forest products.
- Incentives for
action and behavioural chang by transforming theoretical and abstract values of
forest products and services.
Funding: CHF
50-70K ($57-114K) per year for 1-4 years (possbile to exceed with pre-approval)
https://veluxstiftung.ch/funding-areas/forestry/
30.9 | The Frick Foundation:
Starting grants in ALS basic research
For talented early-career
scientists who have already produced excellent supervised work, ready to work
independently and shows potential to be a research leader.
Funding: 100K Swiss francs
($111K) for 2 years
30.9 | Benign Essential Blepharospasm Research Foundation (BEBRF): Research
grant
Supports research
directly related to the cause of, treatments for, and complications derived
from treatments for benign essential blepharospasm or Meige
Syndrome, both forms of cranial dystonia.
Funding: up to $50K for
1 year
https://blepharospasm.org/apply-for-a-grant/
30.9 |
Thermo Fisher Scientific: Oncomine Clinical Research Grant - Molecular
Profiling in Oncology
Investigator-initiated studies and education projects, on molecular
profiling in oncology, with the goal to increase high quality molecular
profiling and to help democratize the future of precision medicine.
Proposals addressing unmet diagnostic needs using next-generation
sequencing for both solid and hematological cancers.
Funding: up to $200K
30.9 | VELUX STIFTUNG
Daylight
Research
Highly
interdisciplinary, on the effects and utilization of daylight in three fields:
- Daylight
and humans
- Daylight
and nature
- Daylight
technology
Healthy
Aging
Bio-psycho-social
approach and support research that aims to sustain or increase the functional
ability and intrinsic capacity of older people.
Funding:
CHF 50-70K ($57-114K) per year for 1-4 years (possible to exceed with
pre-approval)
https://veluxstiftung.ch/funding-areas/daylight-research/
https://veluxstiftung.ch/funding-areas/healthy-ageing/
30.9 | Alzheimer’s Drug Discovery Foundation
(ADDF) – Letter of intent
*
Drug Development: up to
$5M.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/drug-development-rfp
*
Neuroimaging and CSF Biomarker: $600K for 1 year
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers
*
Prevention: up to
$5M for
clinical trials based on stage and scope of research.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/prevention-pipeline
Please
note overhead is not covered.
https://www.alzdiscovery.org/research-and-grants/funding-opportunities
1.10 | LEO Foundation: Education and awareness
grants
Call
opens on Aug. 20, Projects must be carried out in Denmark
Welcomed application:
- Spur the interest and strengthen the capabilities of children and young people within the STEM (science, technology, engineering, and mathematics) fields.
- Disseminate research-based knowledge to the public. increase public awareness about science and its role in developing our society.
- Promote public knowledge and understanding about skin, skin health, and skin diseases.
Funding: below or above DDK 1 ($145K) - different requirements for proposal and evaluation.
https://leo-foundation.org/en/grants-and-awards/research-grants/
\ Call guidelines
3.10 | CurePSP: Grant program
Pathway Grants
Support projects studying
the fundamental neurobiology of PSP and CBD, to improve understanding of diseases
and provide the foundation for future treatments. Studies focusing on
mechanisms common to multiple neurogenerative are strongly encouraged.
Pipeline Grants
Support translational projects
focusing on new therapeutics and biomarkers for PSP and CBD. Aimed to
accelerate the development of therapeutics that have the potential to prevent,
treat, or cure PSP and CBD by accelerating the translation of basic science
discoveries into novel therapeutics.
Funding: Up to $100K for
1-2 years (Non-profit)
https://www.psp.org/for-researchers
5.10 | US
Department of Health & Human Services/Office of Biomedical Advance
Research and Development
Authority (BARDA): Division of Research, Innovation & Ventures (DRIVe) -(Abstracts) (Abstracts may be submitted at any time until the closing date)
AOI #25 - FASTx Nucleic acid-based platform development for
Flexible and Strategic Therapeutics
submissions of projects that
aim to advance the development of rapid response, nucleic acid-based platforms
for the treatment of viral infections from multiple viral families. These
platforms may include, but are not limited to, nucleic acid-expressed mAbs, double-stranded RNA-mediated interference (RNAi),
clustered regular interspaced short palindromic repeat-associated proteins
(CRISPR-Cas), and locked nucleic acids (LNAs).
Funding: up to $750K.
https://drive.hhs.gov/partner.html
14.10 | Promobilia Foundation: Research Projects
Foster the development and
dissemination of technical aids, with a particular emphasis on enhancing
mobility, alongside supporting scientific research to create new aids and
restore mobility and communication capabilities for individuals with
disabilities.
Only projects affiliated
with Swedish organizations, or their equivalents are eligible for application.
In certain instances, projects conducted abroad may also be considered for
application.
Funding: up to 500K SEK
($48K) per year for a max period of 3 years (Non-profit)
https://www.promobilia.se/en/apply-for-project-grants/
15.10 | Angelman Syndrome Foundation
Priority will be given to the following
topics:
- Projects studying or correcting the
heterozygous effect of non-UBE3A genes in deletion.
- Projects studying the potential results of
increasing UBE3A after therapies or for some subtypes of AS.
- Projects studying delivery of therapies and
potential for improvement.
- Symptomatic therapies that impact the daily
life of people with Angelman syndrome and their families.
Proposals that do not address these topics
are still welcome and will be given full consideration.
Funding: $100K per year for 1 or two years
https://www.angelman.org/as-research/call-for-proposals
21.10 | CURE Parkinson's: Quarterly Research Grant Funding Programme
Funds preclinical and
clinical research focused on slowing, stopping, or reversing Parkinson’s.
Funding: up to Ł250K
(GBP) and prioritize projects that are likely to lead to clinical trials in
people with Parkinson’s within 5 years.
https://cureparkinsons.org.uk/for-researchers/apply-for-funding/quarterly-research-grant-funding/
31.10 | The Morton Cure Paralysis Fund (MCPF): Research Grants
Funds activities that
hold promise of identifying therapies (cures) for paralysis in humans. Has
particular focus of placing projects in the research pipeline, that is,
enabling scientists to develop the proof concept data necessary to apply for
larger NIH grants. The development of effective therapies for chronic injury is
a high priority for the organization.
Basic research will be supported if it has clear potential to accelerate
progress at the applied end of the continuum and/or if it reflects innovative
research or a ‘change of direction’.
Funding: $5K to $75K
for 1 year (second year considered, no overhead)
https://www.ra.trdf.co.il/files/MCPF-Research-Guidelines-2023.doc
https://mcpf.org/new-investigator-grant-application/
15.11 | GenScript Life Science: Research Grant
Program
Supporting breakthroughs in life science research areas,
including but not limited to those indicated below. This program is designed to
empower researchers by providing grant funding earmarked explicitly for
purchasing GenScript reagents and services.
Funding: $100K for up to 12 months
https://www.genscript.com/grantprogram.html
https://www.ra.trdf.co.il/files/GenScript_Biotech_Research_Grant_Application_Form_EN.pdf
30.11 | Fritz Thyssen Foundation: Conferences in Medicine and Natural
Sciences, Humanities and Social Sciences
Clear connection to the
German research system (topic, scientist, institute). Interdisciplinary
projects welcomed.
Areas of support:
- History, Language & Culture
- State, Economy and Society
- Medicine and the
Natural Sciences
15 to 20 speakers, not
earlier than 6 months after application submission, not for a staged
conference.
https://www.fritz-thyssen-stiftung.de/en/funding/types-of-support/conferences/
1.12 | Environmental Research & Education Foundation-
Pre-proposals
Topic areas:
Waste minimization, Recycling, Waste
conversion to energy, biofuels, chemicals or other
useful products. This includes, but is not
limited to, the following technologies:
Waste-to-energy, Anaerobic digestion,
Composting. Other thermal or biological conversion technologies, Strategies to
promote diversion to higher and better uses (e.g. organics diversion, market
analysis, optimized material management, logistics, etc.), Landfilling.
Funding: average of $160K for about 2
years
https://erefdn.org/research-grants-projects/how-to-apply-for-grant/
5.12 | Cystic
Fibrosis Foundation
Pilot and Feasibility Awards
Intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.
Funding: $50K per year for up to 2 years
https://www.ra.trdf.co.il/files/Pilot-and-Feasibility-Awards.pdf
https://www.cff.org/researchers/pilot-and-feasibility-awards
Path to a Cure Pilot and Feasibility Awards
Supports research that will accelerate the discovery and development of therapies to restore cystic fibrosis transmembrane conductance regulator (CFTR) function in all patients with cystic fibrosis.
Funding: $50,000 per year for up to 2 years
https://www.ra.trdf.co.il/files/PTAC-Pilot-and-Feasibility-Award.pdf
https://www.cff.org/researchers/path-cure-academic-programs
Research Grants
To support (non-Path to a Cure related) basic science research that will provide new insights that contribute to the understanding of the basic etiology and pathogenesis of cystic fibrosis.
Funding: $150K per year for up to 3 years
https://www.ra.trdf.co.il/files/Research-Grants.pdf
https://www.cff.org/researchers/research-grants
Path to a Cure Research Grants
To support basic science research that may enable the development of new therapies that directly impact CFTR function.
Funding: $150K per year for up to 3 years
https://www.ra.trdf.co.il/files/PTAC-Research-Grants.pdf
https://www.cff.org/researchers/research-grants
30.9.27 | US Army Medical
Research and Development Command: Broad Agency Announcement (BAA) for Extramural Medical Research
(Pre-proposals/pre-applications may be submitted at any time throughout
the 5-year period from the BAA release date to the BAA closing date)
Research Areas of Interest (please see BAA for more details)
I. Military Infectious Diseases Research Program
Research and development of solutions for the prevention, treatment, and
diagnosis of infectious diseases
II. Combat Casualty Care Research Program
A. technologies to stop blood loss, resuscitate the casualty, and limit
the immediate, short-, and long-term deleterious consequences of severe
hemorrhage:
B technologies to diagnose and to limit the immediate, short-, and
long-term impairments that follow TBI
C. technologies to diagnose and reduce acute secondary organ damage
D. The delivery of care during transport
E. Clinical practice of novel/optimized treatments for severe
burn injuries
F. Pain Management
G. Regenerative Medicine
H. Autonomous Care and Evacuation / Medical Assist Support Technologies
(MAST)
I. Medical Countermeasures (MCMs) for Acute Radiation Exposure
J. Combined Injury
III. Military Operational Medicine Research Program
A. Injury Prevention and Treatment
B. Psychological Health and Resilience
C. Physiological Health and Performance
D. Environmental Health and Protection
IV. Medical Biological Defense Research Program
A. Viral, Toxin, and Bacterial Studies
B. Drug Development
C. Identification, Diagnosis, and other Medical Interventions
D. Biosurveillance (BSV)
V. Medical Chemical Defense Research Program
Funding: not specified. Duration: 4 years.
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549112
https://www.grants.gov/web/grants/search-grants.html?keywords=Extramural%20Medical%20Research
18.10.27 | US
Department of Health & Human Services/Office of Biomedical Advanced
Research and Development
Authority (BARDA): Division of
Research, Innovation & Ventures (DRIVe)- (Abstracts) (Abstracts may be submitted at any time until
the closing date)
AOI #20 DRIVe Forward
Aims to develop
products, capabilities, and technologies to detect threats, improve patient
care, including ancillary supplies and resources, as well as novel approaches
to develop, clinically validate, and deploy/distribute MCMs rapidly and
agnostically.
Especially interested in proposals that aim to address
one or more of the following topics:
1. Microbiome-based
therapies
2. Resilience to infection
3. Next-generation vaccines
4. Next-generation therapeutic antibodies
5. Artificial blood products
6. Extremely mobile viral diagnostic platforms for use
in extremely remote settings
7. Non-pharmacological approaches for enhanced immunity
Funding: up to $750K.
https://drive.hhs.gov/partner.html
https://drive.hhs.gov/files/ezbaa_files/DRIVe_EZ-BAA_Special_Instructions_01.pdf
20.11.27 | DOD/ DEVCOM Army Rsearch Laboratory (ARL): Broad Agency Announcement (BAA) Foundational Research (W911NF-23-S-0001)
(Accepting applications on a rolling basis
until the deadline)
Research Areas of Interest (please
see BAA for more details)
DEVCOM
ARL executes intramural and extramural research organized by eleven
competencies
that
provide the Army with foundational expertise and specialized capabilities
grounded in
scientific
excellence and driven by unique Army challenges.
The
eleven DEVCOM ARL competencies are:
Biological and
Biotechnology Sciences
Electromagnetic
Spectrum Sciences
Energy Sciences
Humans in
Complex Systems
Mechanical
Sciences
Military
Information Sciences
Network, Cyber,
and Computational Sciences
Photonics, Electronics,
and Quantum Sciences
Sciences of
Extreme Materials
Terminal Effects
Weapons Sciences
https://www.grants.gov/search-results-detail/344592
For the full
list of opportunities under this BAA:
https://cftste.experience.crmforce.mil/arlext/s/arl-opportunities
31.7.28 | DOD/ United States Special Operations Command
(USSOCOM): Broad Agency Announcement (BAA) Extramural Biomedical and Human Performance Research
and Development (HT9425-23-S-SOC1)
(Pre-proposals/pre-applications may be submitted
at any time throughout the 5-year period from the BAA release date to the BAA
closing date)
Research Areas of Interest (please
see BAA for more details)
1.
Damage Control Resuscitation
2.
Prolonged Field Care (PFC)
3.
Portable Lab Assays and Diagnostics
4.
Force Health Protection and Environmental Medicine
5.
Brain Health
6.
Immune Response
7.
Chronic Pain
8.
Automation of Systematic Reviews and Metanalysis:
9.
Medical Simulation and Training Technologies
10.
Human Performance Optimization
11.
Canine Medicine and Performance:
Most
projects are anticipated to have a total cost at or below $1,500,000 (including
indirect costs). Projects that have a total cost higher than $1,500,000
(including Indirect costs) with outstanding scientific merit that meet a
critical need may be accepted; however the total cost of these projects are not
to exceed $5,000,000.00 (including Indirect costs).
Duration: up to 5 years.
https://www.grants.gov/web/grants/view-opportunity.html?oppId=349586
Open
until suspended | U.S. Air Force (AFOSR):
Research Interests of the Air Force – Engineering, Complex systems, Information
and networks, Chemistry, Physical, Biological sciences (FA9550-23-S-0001)
(Open on an ongoing basis until
superseded)
AFOSR is looking for new basic research ideas and is open to
considering any unique and revolutionary concepts (pre-coordination
is strongly encouraged). Funding ranges are $100-300K per year for 3 to 5
years.
ENGINEERING AND COMPLEX SYSTEMS
·
Dynamic
Materials and Interactions
·
GHz-THz Electronics
·
Energy, Combustion and Non-Equilibrium
Thermodynamics
·
Unsteady Aerodynamics and Turbulent Flows
·
High-Speed Aerodynamics
·
Aerospace Composite Materials
·
Multiscale Structural Mechanics and prognosis
·
Propulsion and Power
·
Agile Science for Test and Evaluation
INFORMATION AND NETWORKS
·
Computational Cognition and Machine Intelligence
·
Computational Mathematics
·
Dynamical Systems and Control Theory
·
Dynamic Data and Information Processing
·
Information Assurance and Cybersecurity
·
Mathematical Optimization
·
Science of Information, Computation, Learning, and
Fusion
·
Trust and Influence
·
Complex Networks
·
Cognitive and Computational Neuroscience
PHYSICAL SCIENCES
·
Aerospace Materials for Extreme Environments
·
Atomic and Molecular Physics
·
Electromagnetics
·
Optoelectronics and Photonics
·
High Energy Radiation Matter Systems
·
Quantum Information Sciences
·
Physics of Sensing
·
Space Science
·
Ultrashort Pulse Laser-Matter Interactions
·
Condensed Matter Physics
·
Astrodynamics
CHEMISTRY AND BIOLOGICAL
·
Biophysics
·
Human Performance and Biosystems
·
Mechanics of Multifunctional Materials and
Microsystems
·
Molecular Dynamics and Theoretical Chemistry
·
Natural Materials and Systems
·
Organic Materials Chemistry
https://www.grants.gov/web/grants/search-grants.html
Foreign - all year round:
DFG – German
Science Foundation: Research Training Group and International Research Training
Groups
Research Training
Groups (comprised of one or more universities) are established to promote young
researchers; they are run by 5-10 professors with expertise in any field. There
are two program profiles: 1) research: focuses on one main topic; and 2) qualification:
enables doctoral researchers to produce independent research findings with
international visibility, and simultaneously qualify for domestic and
international academic and non-academic job market.
International
research training groups are structured doctoral programs run by German
universities in conjunction with universities abroad, promoting systematic
research cooperation from the partner group.
There is a
two-stage proposal process: draft proposal that leads to invitation for full
proposal. Funding is for nine years in two 4.5 year
segments.
http://www.dfg.de/formulare/54_05/
DFG – German
Science Foundation: Grants to Support the Initiation of International
Collaboration
Funds
collaborative activities, such as three-month research stays at partner institutions,
guest visits, or joint workshops, between international partners.
http://www.dfg.de/formulare/1_813/1_813_en.pdf
AstraZeneca: Open
Innovations
Preclinical research
opportunities
Cell therapy: Explore and identify new compounds from
a subset of AstraZeneca small molecules with the potential to act as cell
modulators in regenerative medicine,
Cell modulation with
therapeutic antibodies, novel approaches, and technologies for the generation
of hypoimmunogenic ‘universal cells.
Preclinical
molecules:
Identifying disease targets for active molecules is integral to modern drug
discovery.
Drug Delivery: particularly interested in the
following drug delivery approaches:
- Technologies that facilitate
oral delivery of macromolecules
- Approaches for
elongating dosing intervals, e.g. long-acting delivery systems for peptides and
oligonucleotides that can enable monthly or biannual dosing
- Technologies or
compounds that offer patient-centric approaches to drug delivery and/or offer
attractive alternatives to injectables, e.g. macromolecule transdermal delivery
- Approaches for
targeted delivery of large nucleic acids ready for clinical translation
Preclinical data (no
funding, only collaboration): for data, analytical or computer science research groups that profile
data sets with algorithms to interrogate patterns in data and link to
biological outcomes. Allow to get access to unpublished data. Publications
encouraged.
Clinical research
opportunities (no funding, only collaboration)
Target
identification):
gain access to high-quality diversity screening sets for use in hit
identification.
Clinical molecules: to test our molecules in clinical
indications that they have not previously been tested in.
Human biological
samples): gain
access to a broad range of analytical methods, including genome sequencing, RNAseq, proteomics, metabolomics, and a novel multi-omics
integration pipeline. open to basic and applied researchers with appropriate
patient samples, the ability to share them, and utilize the data generated.
Translational data:
Data, analytical, or
computer science research groups with algorithms to interrogate data patterns
and link them to biological outcomes. Publications encouraged.
CoSolve
CoSolve Sprints - Novel Antibodies Targeting
COVID: innovative solutions to
challenges currently facing our R&D teams.
A. Catalyst Network - open a hub.
Unites entrepreneurs,
start-ups, academics, governments, healthcare institutions and other industries
from all around the world under one common goal.
https://az-portal-ex.idea-point.com/Default.aspx?groupid=null
Sanofi
Regeneron: Global Innovation Grant – Pathways in Type 2 Inflammation
Research in
type 2 inflammation and its associated diseases, including atopic dermatitis,
asthma and chronic rhinosinusitis with nasal polyps or other type 2
immune-mediated diseases that are relevant in clinical practice. Funding:
up to $1 million
National
Spasmodic Dysphonia Association (NSDA)
Supports research
for spasmodic dysphonia and related voice conditions. Funding: 75,000 for 1
year.
https://dysphonia.org/research/nsda-research-grants/
MSSNG
- genomic database on AUTISM
Genomic
database on autism. A resources to enable the
identification of many subtypes of autism, which may lead to better
diagnostics, as well as personalized and more accurate treatments
https://research.mss.ng/visitors/about
MdDS Balance Disorder Foundation Research Grant
supports
biomedical research that generates evidence-based data leading to knowledge
regarding the cause, treatment, or prevention of Mal de Débarquement
Syndrome (MdDS).
Funding:
The size of the grant is determined on a case-by-case basis. The grant may
cover indirect costs or institutional overhead (limited to 10%) for
applications in excess of $30,000 direct costs.
https://mddsfoundation.org/apply-for-a-grant/
Rett Syndrome
Research Trust (RSRT)
RSRT does not
have funding calls. We do however accept unsolicited
proposals. Please submit a short (between one and two pages) letter of intent
to monica@rsrt.org outlining your project,
timeline, and rough budget. There are no deadlines for submission.
Myrovlytis Trust:
Birt-Hogg Dubé Syndrome, related kidney disorders and osteosarcoma
Promotes research
into molecular genetics, clinical investigations and
therapeutic technologies so as to better understand, prevent, diagnose, relieve
and ultimately cure symptoms caused by Birt-Hogg-Dubé (BHD) Syndrome,
BHD related kidney disorders and osteosarcoma.
Welcome initial
pre-proposals before submission of the full grant application form.
Pre-proposals should be emailed to: grants@myrovlytistrust.org.
https://myrovlytistrust.org/home/apply-for-funding
Cystic Fibrosis
Foundation: Path to a Cure — Pioneer Award - Rolling competitive LOI
(Closes on
December 13, 2024)
For exceptional
investigators developing paradigm shifting technologies that could ultimately
lead to a cure for CF. Proposals should be
ambitious and
utilize cutting edge techniques and strategies.
https://www.cff.org/researchers/path-cure-pioneer-award
https://www.ra.trdf.co.il/files/Path
to a Cure.pdf
Lundbeck Foundation: Frontier Grants
Facilitate transitions from basic research
to attractive prospects for biotech investors, to advance mature research
projects to become financeable and commercially tangible venture opportunities.
The research must be affiliated with a
Danish non-commercial research institution – international collaboration is
allowed.
Funding: up to DKK 5M ($730K) over 18
months
https://lundbeckfonden.com/uddelinger-priser/ansoegere/apply-grants/frontier-grants
Cancer
Research:
The Johns Hopkins University School of Medicine: Neurofibromatosis
Therapeutic Acceleration
Program (NTAP)
Accepting applications on a rolling basis
To accelerate development of effective treatments for NF1 associated peripheral nerve sheath tumors.
No fixed budget, not set time frame (usually 2-3 years)
https://www.ra.trdf.co.il/files/PRDESC6990.pdf
Rising Tide
Foundation for Clinical Cancer Research: Cancer Research Program – LOI
Supports
patient-centered clinical research that has the potential to positively impact
the lives of cancer patients at the earliest opportunity. We do not provide
funding for basic research. Two umbrella themes: Improved Patient Outcomes and
Science of Early Detection and Intervention. Funding: unspecified, based on the
objectives of each grant and availability. Duration up to 5 years. No overhead. Nonprofit.
https://www.risingtide-foundation.org/freedom-in-practice/
Lyla Nsouli Foundation:
Diffuse Intrinsic Pontine Glioma (DIPG)
Supports
research to improve the prognosis and find a cure for brain cancers, with a
focus on Diffuse Intrinsic Pontine Glioma (DIPG). Application on a rolling
basis. Funding: up to
$300,000.
www.lylansoulifoundation.org/research-and-grants/what-we-fund.php
Pediatric Brain
Tumor Foundation: Brain Tumor / Low-grade Glioma ad Astrocytoma (PLGG/PLGA) Research Grants
Proposals related to basic and
translational projects that can advance understanding of the underlying biology
of the development and treatment of PLGA tumors will be considered.
Investigators in the early years of their careers are encouraged to apply. Funding
can be awarded over one to three years.
www.curethekids.org/research/apply-for-funding
James S.
McDonnell Foundation: Collaborative Activity Awards supports research in 3 areas: Bridging Brain,
Mind, and Behavior; Complex Systems; and Brain Cancer Research. These awards
support study panels, research networks or other ways of pushing work on
mind/brain forward outside the usual mechanism of investigator-initiated
research proposals. The collaborative award process is not used to support
meetings, conferences, etc.
www.jsmf.org/apply/collaborative/index.htm
Accelerate
Brain Cancer Cure: Basic and Clinical Research Grants - Initial research summary
Aim:
Accelerating the development of new brain tumor treatments, at each stage of
the drug development pipeline, to ensure promising leads are advanced as
quickly as possible. Request to initially submit a 1000 word
research summary.
http://abc2.org/smarter-research/how-we-fund
Neurological
Disorders and NeuroScience:
Cure LGS 365
Research Grants: Lennox-Gastaut Syndrome
Lennox-Gastaut syndrome (LGS) is a developmental brain disorder
that frequently evolves from early-life-onset epilepsy. The LGS Foundation
accepts unsolicited proposals year-round to seed new LGS research projects.
Projects may be funded at the $25,000, $50,000, or $75,000 level.
https://www.lgsfoundation.org/365-research-grants/
CMT Research
Foundation - Funding Priorities - LOI
Supports
translational research to support promising therapeutic approaches for the cure
of CMT diseases. Research funding will be targeted (but not limited) to the key
focuses here after: Pharmacodynamic Barriers; CMT Molecular Drug Targets; Pathophysiologically Relevant Animal Models and Stem Cell
Derived Cellular models of CMT. Funding: $100,000-$150,000 for 1 year.
This funding is
available on a rolling basis. To ensure that the proposed research is aligned
with the funding focus, applicants are required to first submit a one-page
letter of intent.
CHDI Foundation
- accelerating theraputic development for
Huntington's disease (LOI)
CHDI Foundation
is exclusively dedicated to collaboratively developing therapeutics that will
substantially improve the lives of individuals with HD
Funding and
project duration: unspecified
https://chdifoundation.org/academic-proposals/
Alzheimer’s Association: Global Real-World
Data Platforms (ALZ-RWD)
Accept submissions on a rolling basis
Discovery, evaluation
and evolution of novel avenues for the diagnosis, prevention, treatment and
care of Alzheimer’s and other dementia.
Funding: from $100K up to $1M for 12-24
months (no overhead)
https://www.ra.trdf.co.il/files/Global
Real-World Data Platforms.pdf
Alzheimer’s
Drug Discovery Foundation (ADDF): Diagnostics Accelerator (DA)
Development of
cutting-edge biomarkers and novel diagnostic technologies that will aid in
Alzheimer’s diagnosis and clinical trial design. Research funded to date
focuses on various methods and targets including blood tests in various stages
of development, as well as eye scans and digital tools. These awards
focus on true collaboration among renown clinicians, directly involved with
patients and understand the disease, scientists developing the tests, and
diagnostics companies that understand the regulatory pathways – driving
research and product development.
The program has
two sub-domains with funding of up to $500K each: Peripheral Biomarkers /
Digital Biomarkers
www.alzdiscovery.org/research-and-grants/diagnostics-accelerator
* www.alzdiscovery.org/research-and-grants/funding-opportunities/diagnostics-accelerator-program
* www.alzdiscovery.org/research-and-grants/funding-opportunities/digital-biomarkers
Cure
Alzheimer’s Fund – rolling
acceptance of LOIs
Aim: to fund
research with the potential to accelerate a cure or disease-modifying treatment
for Alzheimer’s disease.
Current areas
of investigation: Fundamental / Translational / Drug discovery /
Preclinical and clinical drug development.
Funding: not
specified.
Non-profit -
Please contact Research Authority if planning to
submit.
https://curealz.org/the-research/grant-process/
STXBP1
Foundation: (LOI)
Aim: broaden understanding
of STXBP1 biology and develop safe and transformative therapies for STXBP1
related disorders.
These areas
include but are not limited to the following: Biomarkers and clinical
endpoints development / Neurodegeneration / Pathomechanisms of STXBP1 mutations and genotype-phenotype
relationships / Non-CNS functions of
STXBP1 / New Therapeutics and Drug repurposing.
Seed
Grant: up to $25K for 1 year.
Trainee
Grant: up to $60K for 1.
Innovation
Grant: up to $100K for 1 year.
(No
overhead).
https://www.stxbp1disorders.org/applyforagrant
Parkinson's Foundation: Conference Awards
Support the gathering of experts in the field
working to address unsolved clinical or basic science problems relevant to
Parkinson's disease.
Funding: $10K - $15K per award
Please contact Grants@Parkinson.org if you
are interested to apply.
Michael J. Fox Parkinson Foundation: Parkinson's
Disease Therapeutics Pipeline Program
Aim: to accelerate pre-clinical and clinical therapeutic
development of interventions that may reduce, slow or prevent
disabling motor or non-motor symptoms of Parkinson’s disease not well managed
by current treatments.
Funding: up to $2M over
18-24 months. Duration: 1 to 2 years for pre-clinical
programs and 2 to 3 years for clinical programs
https://www.michaeljfox.org/grant/parkinsons-disease-therapeutics-pipeline-program
Other
The LAM
Foundation: Out-of-Cycle Grant Opportunities
Bridge funding
on a case-by-case basis. Targeted towards Principal Investigators (PIs) that
have an external grant under review and will exhaust current funding prior to
the Notice of Award, equiring funds to sustain their
program/laboratory, or have a previously submitted grant being prepared for
resubmission but need funding to execute experiments or retain personnel during
a funding gap.
Funding: up to
$75K in increments of $25K for a maximum period of 1 year
For more
information about bridge funding and prior to applying, please contact The LAM
Foundation at research@thelamfoundation.org.
https://www.thelamfoundation.org/investigators/funding-opportunities/
FRAXA Research
Foundation: FRAXA Fellowships
Priority is
given to research with a translational or preclinical focus on Fragile X, which
has potential to lead to improved treatment.
Funding: $50K
per year for up to 2 years (Non-profit)
https://www.fraxa.org/fragile-x-research/grant-application/
The American
Tinnitus Association (ATA): Innovative Grants Research Program
Application
on a rolling basis, LOI to: grants@ata.org is required 1-month
before applying.
1. Established
Investigators, max $60K/year for 2 years
2. Early Investigators,
max $25K/year
Encourages a
multidisciplinary approach to solve the complex and variable experience within
tinnitus research, clinical care, and patient outcomes.
https://www.ata.org/wp-content/uploads/2023/02/ATA_Grants_Instructions.pdf
Humboldt Foundation
Friedrich Wilhelm Bessel
Research Awards
Awarded to outstanding
accomplishments in research, if they are expected to continue producing
cutting-edge academic achievements and have a lasting impact beyond their area
of specialization. Academics, regardless of their discipline or nationality,
may be nominated, provided that they have received
their doctoral degree within the past 18 years. Award winners are invited to
conduct a research project of their own choosing in Germany in close
collaboration with a specialist colleague. Project duration 6-12 months. Award amount is €45,000. Self-nomination is not possible.
Nomination processing normally takes up to six months, selection committee
meetings are held twice a year – currently at the beginning of spring and in
early autumn.
http://www.humboldt-foundation.de/web/bessel-award.html
Humboldt Research
Fellowship for Experienced Researchers
For highly-qualified
scientists and scholars from abroad, who completed their doctorates less than
12 years ago to spend extended periods of research (6-18 months; may be divided
up into a maximum of three blocks) in Germany. Candidates are expected to have
their own, clearly defined research profile. Funding: fellowship of €3,150 per
month. The selection committee meets every year in March, July
and November.
http://www.humboldt-foundation.de/web/humboldt-fellowship-experienced.html
Humboldt Research Award
The award is granted in
recognition of a researcher's entire achievements to date to academics whose
fundamental discoveries, new theories, or insights have had a significant
impact on their own discipline and who are expected to continue producing cutting-edge
achievements in the future. Award winners are invited to spend a
period of up to one year cooperating on a long-term research project with
specialist colleagues at a research institution in Germany. Nominations may be
submitted by established academics in Germany or by award winners of the
Humboldt Foundation working abroad, provided that the nomination is made
jointly with a colleague working in Germany. Direct applications are not
accepted. The award is valued at €60,000. Selection Committee meetings are held
twice a year – currently at the beginning of spring and in early autumn.
http://www.humboldt-foundation.de/web/humboldt-award.html
Reimar
Lüst Award for International Scholarly and Cultural Exchange
Highly respected humanities scholars and
social scientists. For multipliers making exceptional contributions in and
through science to the long-term advancement of bilateral relations between
Germany and their home countries. Part of the ‘Humboldt
Research Award’.
Foundation for Food &
Agriculture Research (FFAR):
Research Concept
Funds food and agriculture science that addresses large-scale
challenges to develop actionable knowledge and solutions.
*Soil health; *Sustainable
water management; *Next generation corps; *Advanced animal system; *Urban food
systems; *Health agriculture Nexus.
Funding: Not specified
(Please note: Matching).
https://foundationfar.org/grants-funding/open-opportunities/
The Campbell
Foundation Funding AIDS Research: Research Grants (LOI)
LOIs should
include a brief description of the research aims, an approximate one-year budget,
a list of collaborating research teams, how it is novel research, and an
explanation of how the project will apply to the HIV community at large within
five to seven years from date of completion. Funding from $60,000 to $100,000
for 1 year. (Please contact
research Authority if planning to submit- nonprofit).
http://www.campbellfoundation.net/grant-requests
Rising Tide Foundation: Programs in Libertarian, Social/education,
and Cancer Funding
- Libertarian topics: leadership
development, capacity building and training across a range of issues.
- Social/education topics: projects
that promote effective and scalable practices to enhance educational reform.
Funding/duration not specified.
http://www.risingtide-foundation.org/#!grant-programs/c1ugo
U.S.
DOD/Defense Threat Reduction Agency: Fundamental Research to Counter Weapons of Mass
Destruction (WMD) BAA – White Paper
Topics: WMD sensing
and recognition (interactions between materials and various electromagnetic
phenomena, molecules, nuclear radiation, and particles); Network sciences
(response, resilience, and recovery of physical networks after exposure, rapid
discovery, theories and representations for low observable WMD-related radical
ideation from social networks); Protection (physical, biological, and
engineering sciences to protect personnel, sensitive electronic systems, and
structural infrastructure from the effects of WMD); Defeat (improving energetic
materials for use against WMD facilities and systems); Securing WMD (handling,
transport, control of access, or eliminating WMD components); Cooperative
fundamental research to reduce the global threat of WMD in collaboration with a
broad range of global research partners; Chemical and Biological Defense.
http://www.dtra.mil/Research/BasicandAppliedScienceDepartment/ResearchFundingOpportunities.aspx
http://www.grants.gov/web/grants/view-opportunity.html?oppId=275322
European Molecular Biology Organization
(EMBO) – various opportunities
Short-term fellowships: To advance molecular biology research by helping scientists
to visit another laboratory for applying a technique not available in the home
laboratory. The fellowships are only provided for exchanges between 2 EMBC
member states and are not awarded for exchanges between two laboratories within
the same country. The fellowships cover travel plus subsistence of the fellow
alone.
http://www.embo.org/funding-awards/fellowships/short-term-fellowships
Young Investigator: supports life scientists who have been group leaders
for less than four years at the time of application in setting up their
laboratories.
Financial support for networking for four
years and benefit from training opportunities, support for their lab members
and mentoring.
https://www.embo.org/funding/fellowships-grants-and-career-support/young-investigator-programme/
Travel Grants: travel
grants are provided for participants to attend EMBO practical courses, lecture
courses, symposia, and other select EMBO events. Covers travel only.
http://www.embo.org/funding-awards/travel-grants
Workshops: present
and discuss the latest findings in their subject areas related to the life
sciences
https://www.embo.org/funding/funding-for-conferences-and-training/workshops/
Alpha-1
Foundation: Out of-Cycle ***Research grants in Alpha-1 Antitrypsin (AAT)
Deficiency
Purpose: to
support large, typically clinical grants that do not fit into the in-cycle
grant program. The investigator should contact the Foundation before
considering applying for an out-of-cycle application.
https://alpha1.org/grant-opportunities/
Beyond Batten
Disease Foundation – rolling acceptance of LOIs
BBDF is interested
in novel targets and therapeutic approaches for juvenile Batten disease. Areas
of interest are outlined at agency web site. Procedure
is to submit a Letter of Intent (LOI) that provides a preliminary overview of
the project, resource, or conference. Awards vary between $5,000 up to $2-million, with an average academic grant of $150,000 over
two years.
https://beyondbatten.org/research/about-funding/
Immune
Tolerance Network (ITN): Clinical Trials and Assays & Biomarkers in
diseases of the immune system - Concept
Proposals
ITN is a
non-profit, government-funded consortium of researchers working together to
establish new treatments for diseases of the immune system. The ITN conducts
clinical trials of specialized immune tolerance therapies in the following
areas:
* prevention of organ transplant rejection (in liver, kidney
and islet transplantation)
* treatment of autoimmune diseases (such as type 1 diabetes,
multiple sclerosis, lupus and others)
* prevention and treatment of allergies and asthma
Clinical
Trials: ITN accepts applications for novel clinical trials, in the areas of:
Islet
Transplantation
Kidney &
Liver Transplantation
Autoimmune
Diseases
Allergy &
Asthma
Assays &
Biomarkers: ITN accepts applications for the development of novel tolerance
assay or mechanistic studies, for the purposes of establishing new surrogate
markers of immune tolerance and investigating the mechanisms of clinical
tolerance.
** ITN does NOT
accept proposals for non-human or preclinical studies.
www.immunetolerance.org/professionals/proposals/guidelines
Jeffrey Modell
Foundation:
*Specific
Immune Defect Research Program -Goal: to
support the study of mechanisms and presentation of specific defects of the
immune system, leading to a better understanding of the conditions and their
impact on overall health outcomes.
*Children
Immune deficiency project – Goal: to alleviate disease, seek cures,
and improve the quality of life of children affected with Primary
Immunodeficiency.
Funding: up to
$25K / yr for up to 2 years.
(Applications
accepted on a rolling basis) Note: please
contact Research Authority if planning to submit - overhead not covered
http://www.jmfworld.com/medical/research-grants/research-grants-1
Thrasher Research
Fund: Pediatric Research
Supports
medical research aimed to improve children's health in a variety of significant
pediatric problems, with an emphasis on projects that have the potential to
translate into clinically meaningful results within a few years. Both incidence
and severity are considered when determining the significance of the proposed
topic. Funding: the median award amount is $300K over 3 years.
https://www.thrasherresearch.org/SitePages/al-thrasher-award.aspx
Coalition to Cure Calpain 3: Research Grant
(Contact
Research Authority if planning to submit- overhead)
Support for
research for enabling further translational development that can lead to
meaningful therapeutic approaches for limb-girdle muscular dystrophy, type 2A/calpainopathy (LGMD2A). In support of this goal C3 funds
projects that are likely to expand the understanding of calpain 3 and LGMD2A
disease.
http://www.curecalpain3.org/research/
Action
Duchenne: Research Grants - Pre Preposal
Applications
considered throughout the year. The general research strategy is to increase
understanding of Duchenne muscular dystrophy and to support research into,
among other topics, novel ideas by Duchenne healthcare professionals, Outcome
measures and natural history data, multidisciplinary standards of care,
across the age spectrum. Range of previously funded projects $30K-$175K.
https://www.actionduchenne.org/how-do-we-choose-research-to-fund
Found Animals
will provide up to $50 million in multiple, multi-year international grants
through the Michelson Grants in Reproductive Biology, for promising research in
pursuit of non-surgical sterilization products or technologies for use in dogs
and cats. The Foundation seeks proposals for up to $250,000 USD per year for up
to 3 years of funding.
http://www.michelsonprizeandgrants.org/
Fanconi Anemia
Research Fund (FSRF): Research Grants
Funds
interdisciplinary & translational research that will lead to rapid
discovery & development of therapies or strategies that treat, control, or
cure Fanconi anemia (FA).
Priorities:
- (Top priority)
To define the pathogenesis of cancers including head & neck &
anogenital squamous cell carcinomas that affect persons with FA, and to develop
strategies for early detection, prevention, treatment, & cure.
- To understand
how alteration of the FA genes and their products lead to the clinical
manifestations of the disease.
- To determine
the causes of bone marrow failure, myelodysplasia, and leukemia in individuals
with FA, and to develop strategies to prevent, treat and cure these disorders.
- To identify
practical and proactive management strategies that families and persons with FA
can use to develop and maintain a high quality of life.
- To support
the creation of shared resources, databases, and technologies for the
international FA research community.
Funding:
$25,000 - $250,000 for 1-2 years
www.fanconi.org/explore/apply-for-grant-funding
The Lymphatic Malformation
Institute (LMI)
Focus:
advancing the understanding of the lymphatic system and, specifically, of the
rare lymphatic malformations, generalized lymphatic anomaly (GLA)/
Lymphangiomatosis and Gorham-Stout disease. Funding for 1 year.
Please Contact
the research authority before applying (no overhead)
http://www.lmiresearch.org/funding-model/
National
Organization for Rare Disorders (NORD): Research Grants (LOI):
Scientific
studies and/or clinical research studies to address below
orphaned rare diseases.
-Cat Eye
Syndrome – 1 grant of up to $30,000 for scientific and/or clinical
research studies
-Malonic
Aciduria – 1 grant of up to $50,000 for scientific and/or clinical
research studies
-Post-Orgasmic
Illness Syndrome –1 grant of up to $31,000 for scientific and/or
clinical research studies
https://rarediseases.org/for-clinicians-and-researchers/research-opportunities/requests-proposals/
James S.
McDonnell Foundation: Collaborative Activity Awards supports research in 3 areas: Bridging Brain,
Mind, and Behavior; Complex Systems; and Brain Cancer Research. These awards
support study panels, research networks or other ways of pushing work on
mind/brain forward outside the usual mechanism of investigator-initiated
research proposals. The collaborative award process is not used to support
meetings, conferences, etc.
www.jsmf.org/apply/collaborative/index.htm
Microsoft Azure
for Research Award Program – Bi-monthly RFPs
Microsoft
Research is soliciting proposals for the use of Microsoft Azure in research. We
welcome research proposals from any branch of scholarly activity. We review
these proposals on the fifteenth of even-numbered months (April, June, August,
and so forth).
http://research.microsoft.com/en-us/projects/azure/default.aspx#award-program
Jain
Foundation: Research Grants (Dysferlinopathies)
The explicit goal
of the Jain Foundation is to expedite development of a treatment or cure for
the dysferlinopathies (LGMD2B and Miyoshi Myopathy).
http://www.jain-foundation.org/scientific-resources/apply-funding#pre-proposals
American
Fibromyalgia Syndrome Association (AFSA)
Priority Areas
for Research:
Sleep-Related
Priorities: to gain a better understanding of the relationship between the
neurobiology of sleep in people with FMS and the
various symptoms of this condition.
Other Important Priorities: listed in the website.
Funding: Up to
$50,000 for 1 Year. )No overhead)
http://www.afsafund.org/grant.htm#priority
Restless legs
syndrome (RLS) Foundation: Small research grants
Funding
priorities include basic and clinical research to promote a better
understanding of the disease, advance new treatments and find a curefor RLS. The Research Grant
Program invites innovative approaches, interdisciplinary studies
and support of promising postdoctoral candidates. The primary areas of funding
have been genetics, epidemiology, iron regulation, neurophysiology
and animal models/treatment.
Funding: average award is $35,000 per year. (No overhead)
https://www.rls.org/research-grants/apply-for-a-grant
PCDH19
Alliance: Research Grants
Funds research
directly towards understanding the expression of the PCDH19 gene and the
function of the PCDH19 protein, finding therapeutic treatments, and a cure for
PCDH19 Epilepsy. Funding: between $25,000 -$75,000 for 1 year.
https://www.pcdh19info.org/copy-of-patient-assistance-grant
International foundation for CDKL5
research: IFCR Grant Program (LOI)
Priority areas:
1. Research dedicated to furthering the
understanding of CDKL5 function to
inform the development of targeted, novel therapies.
2. Transformative research to enhance our
understanding of the cellular,
molecular, genetic and systems-level
mechanisms contributing to the
pathogenesis of CDKL5 deficiency disorder, facilitating the continued
investigation of disease-modifying strategies.
3. Development of high-throughput
techniques (and relevant animal/cellular
models) to assess the potential efficacy of therapeutic interventions against
phenotypic deficits of CDKL5 deficiency disorder.
4. Translational and clinical research
that will facilitate elevated understanding
of the natural history of CDKL5 deficiency disorder as it relates to symptom
progression (including but not limited to seizures and cognitive delay),
pharmacosensitivity, and response to
behavioral/supportive therapies.
https://www.cdkl5.com/research/request-for-proposals/
Diamond Blackfan Anemia
Foundation: Research Grant
Aim: developing a clearer understanding of
Diamond Blackfan Anemia (DBA) and finding
the best therapy and, ultimately, a cure for this disorder.
https://dbafoundation.org/our-research/
https://dbafoundation.org/research/grant-proposal-forms/
Shire (Medical Research): Investigator
Initiated Research (IIR)
Shire provides IIR grants with the intention
of improving medical and scientific knowledge through the generation of new or
confirmatory scientific and/or clinical information.
IIR study designs supported by an IIR
grant may include but are not limited to:
· Epidemiological, preclinical (in vitro or in
vivo animal) or clinical investigations
· Interventional or observational
· Prospective, cross-sectional or
retrospective
Link to Areas of Interest
https://www.shire.com/research-and-development/investigator-initiated-research/areas-of-interest
Bayer: Center
of Expertise in Tropical Agriculture (CEAT)
CEAT Latin
America welcomes collaborations on novel approaches relating to sustainable
crop farming in tropical environments. Aiming to enable technologies, approaches and services from ideas to marketed products in
order to anticipate trends and support farmers’ decision-making in tropical
agriculture. The research can be related to (but not limited to) resistance
monitoring (weeds, pests and diseases), future threats
to tropical agriculture (new pests), digital farming, automatic / online
systems for pest monitoring, integrated disease, weed, and insect
management/control, combined seeds and crop protection strategies and improved
crops for higher yields. This program is open to application on a rolling
basis. Funding limit and program duration is Discretionary.
https://innovate.bayer.com/programs/ceat-center-expertise-tropical-agriculture#application-process